Podcasts about Ge

Operation Epic Fury continues targeting Iran, principally with airpower. This week, we get the strategist's view from former Air Force planning chief LtGen Clint “Q” Hinote, and it's a mind-blowing doozy. Airpower vs ships. The limits of autonomy. Getting the person out of the loop. Next-war tech. The value of decapitation. Plus the week's headlines in airpower. Powered by GE!

Michelle Direnzo talks about the role of education in her success and how designations strengthened her confidence and client conversations. GE-8809407.1(3/26)(Exp3/30)

The crew discusses the UK removing tariffs on offshore wind equipment, Vineyard Wind’s final blade shipment from New Bedford, and Ming Yang joining Germany’s offshore wind association. Sign up now for Uptime Tech News, our weekly newsletter on all things wind technology. This episode is sponsored by Weather Guard Lightning Tech. Learn more about Weather Guard’s StrikeTape Wind Turbine LPS retrofit. Follow the show on YouTube, Linkedin and visit Weather Guard on the web. And subscribe to Rosemary’s “Engineering with Rosie” YouTube channel here. Have a question we can answer on the show? Email us! The Uptime Wind Energy Podcast brought to you by Strike Tape, protecting thousands of wind turbines from lightning damage worldwide. Visit strike tape.com. And now your hosts.  Allen Hall: Welcome to the Uptime Wind Energy Podcast. I’m your host, Allen Hall. I’m here with Matthew Stead, Rosemary Barnes and Yolanda Padron. And the UK is really gearing up for offshore wind and they’re making some really smart moves and. One of them is, uh, the change in tariffs. So the British offshore wind manufacturers have been fighting really an uphill battle for a long time and for years. The companies that build turbines and components in the UK have faced import tariffs on the materials needed most, which tends to be steels like steel. Uh, cables, specialized parts from overseas all carried a tariff with it. Well, now the federal government has acted to [00:01:00] remove those tariffs on offshore wind equipment. The move is expected to save UK manufacturers tens of millions of pounds every year. And for an industry trying to cut costs and scale up that kind of relief could make the difference between winning. Losing contracts, and I’m surprised the UK has waited this long and I think other countries have the same problem. Obviously the US is taring the heck out of everything at the minute, but uh, a lot of European countries do put tariffs on the raw materials and the components that are used to make wind turbines. That’s not a smart long term move if you’re trying to deploy. Gigawatts of offshore wind.  Matthew Stead: Well, I, I think, uh, the recent events in the world show that energy security and not importing energy is a wonderful thing. And so this completely aligns with that, um, that objective. So I think that’s why we all agree with you, Alan. Allen Hall: Well do, is there a, a. A threshold here where other countries start to do it [00:02:00] and for whatever reason there’s, there’s tends to be tariffs on energy in all forms of it. Right. And there and on steel in particular, that seems to be a big area of concern. Are we gonna start to see some of those come down just to lower the cost of wind turbines and to deploy the middle of the water? ’cause there is a lot of steel in an offshore wind turbine.  Matthew Stead: It’s been like China. I mean China has, you know, a lot of clean energy, low cost energy and it is to their advantage. So I, I think it’s a entirely logical approach and I would’ve thought it’s, if you’re a good on policy, you would definitely be looking at this. Allen Hall: Is this has been a concern of the UK steel industry, which has been diminishing over the years? Uh, so it’s always been a pain point with the uk. They’ve been trying to stand up their own steel industry and forever they had a big steel industry In the uk you think of all the. The steel that was built from late 18 hundreds all the way up to the 1980s and nineties. Uh, but it does sound like you, you gotta pick and choose your battles here. And maybe the UK has [00:03:00] finally said, okay, the, the steel battle is a separate issue within offshore wind, and maybe we gotta do something different.  Matthew Stead: I mean, I think Australia did the same thing ages ago. I mean, we had a car, car industry and you know, we just didn’t have the scale. So, you know, Australia’s picking its battles and um, yeah, I mean, you can’t be good at everything, so you know why not. Uh, get the, the lower cost energy and um, deal with it that way.  Rosemary Barnes: Australia has actually just announced, you know how Australia’s got the policy to support clean energy technology manufacturing in Australia. And they started with, um, solar panels and then they’ve also got something related to battery cells. Well, they just announced wind turbine tower manufacturing, um, which is very simple. The reason why Australia doesn’t have, um, wind turbine tower manufacturing anymore. Is just because we can’t compete on price with Asia, um, in general and China specifically. It’s interesting now to be like, okay, let’s support Australian [00:04:00]manufacturing of wind turbine towers when like there’s no technological barrier. It’s pure cost, cost issues. I would really love to see the Australian government supporting some of the new manufacturing methods and you know, like we’ve seen that Fortescue has invested in. Um, in Ena Lift, the Spanish, Spanish company, um, ESCU has, has bought their tower manufacturing. Um, it’s, it’s like modular, advanced thing that’s gonna work well for remote areas. Otherwise it’s just like, pay a bunch of money so that we can make towers more expensively, but we can sell them at a competitive rate with the Chinese. And I don’t know, to me that’s not very strategic. I always prefer we support the next, the next thing.  Allen Hall: Whatever happened to spiral welding and making towers on site. I think that died about a year or two ago because they were trying it here in the United States and about building ’em at the wind farm. But it sounded like just setting it up to [00:05:00] build the spiral mechanism, the, the cold, uh, forming plus all the welding on top of it. It got to be so expensive to install on site that it was just easier to, to build a central location, which I think they were going for. I’m not even sure that in today’s world, because of the advanced technology in the existing way of manufacturing is so good and inexpensive that it makes any sense to try anything else. It just seems like it’s, there’s just stamping out parts right now.  Rosemary Barnes: Oh, no. I mean, we definitely need new, new methods because we’re really constrained on how tall towers can get if you just wanna make a steel cylinder and ship it out in, you know, whole pieces, like whole cross sections and. Um, put them together vertically. That’s you. You know, like we’ve, we’ve gotten about as tall as we’re gonna get for that because if you want to go any taller, you’re gonna have to start massively increasing the thickness of the tower to make it stiffen up. And that just means way more steel to keep material costs reasonable. You need to increase the diameter, um, beyond [00:06:00] what you can transport on the road. Um, but I think that it’s like the, the, the problem is definitely real and well established, but it’s like with many other. Problems. You know when you start thinking, okay, we’ve got a solution to this problem at that time, there aren’t other solutions, so you’re sure that you know you’re gonna win. And so spiral welding was one of the early ones. Oh, we can fix this problem, but. While they’re developing that and trying to get the capabilities where it needs to be, the cost down, you’ve got a dozen other competing ways that you could solve that problem. And they include like, um, some manufacturers, I think Vestus is one. They’re cutting longitudinally. And so instead of, um, shipping out towers in a single cross section, it’ll be like four. And then they’re bolted together on site. Um, and then Concrete Towers is another one. The Naber Lift, um, thing that I mentioned.  Matthew Stead: Wooden towers.  Rosemary Barnes: Yeah, wooden Wooden towers is, uh, another one I’ve covered, uh, [00:07:00] on my YouTube channel. Matthew Stead: They really should make them out of carbon fiber, shouldn’t they?  Rosemary Barnes: Well, I have, it’s not, it’s You’re saying that as a, as a crazy thing. It’s not, it’s not such a crazy thing. And I have, I have, I have looked into it. You wouldn’t do it outta carbon fiber. You’d do it outta glass. Um, there’s a lot of. There’s a lot of benefits to it, and I actually do believe that we might eventually see like 3D printed glass, um, towers. Allen Hall: No.  Rosemary Barnes: Now we’re just getting into our standard. I, I believe the future might look different to the, to the present day, and Alan never thinks that anything’s ever gonna change.  Matthew Stead: I would’ve. 3D uh, printed concrete towers would have some logic.  Rosemary Barnes: There’s been pilots of 3D printed concrete, concrete towers. I’m, I’m pretty sure GE had a, um, a project on that and there might have been somebody else that did, took it a bit further. It’s all possible. It’s also like concrete towers are, are good, but it is local. Like it depends on having the right materials around locally. ’cause you don’t want to have to transport Hess of. Concrete and water to site. Um, [00:08:00] so yeah, anyway, the point is that like, just because you’ve identified a real problem and you’ve got a solution to it, if you are gonna take five or 10 years to develop your technology and get it to the right price point, you are not gonna be the only, the only solution anymore. So people often like massively overestimate how valuable their idea is. Um, and by the time that it’s ready, it’s not the best solution anymore. So I think like the lesson from that is to just. You need to just move really, really fast and keep your peripheral vision available to see what other technologies are developing in tandem and know when, when to pull the pin. If you are no longer, you no longer have a path to be the best solution, then. Stop. Even if you’ve got 90% of a solution, don’t bother with the last 10%. If you’re never gonna sell it, you know it’s a waste go. Um, let, let all your smart people work on something else. Allen Hall: Delamination and bottom line, failures and blades are [00:09:00]difficult problems to detect early. These hidden issues can cost you millions in repairs and lost energy production. C-I-C-N-D-T are specialists to detect these critical flaws before they become expensive burdens. Their non-destructive test technology penetrates deep to blade materials to find voids and cracks. Traditional inspections, completely. Miss C-I-C-N-D-T Maps. Every critical defect delivers actionable reports and provides support to get your blades. Back in service, so visit cic ndt.com because catching blade problems early will save you millions. Can we pull the pin? On digital twins. I came across another company that was pushing digital twins in the wind turbine space. And I thought, I thought we got rid of that a year ago. Can we stop doing that?  Rosemary Barnes: I, um, in general, like I think a lot of times you see digital twins and I can’t see the point, but there are some applications where you [00:10:00] definitely can,  Matthew Stead: uh, I can add on the digital twin, so the IEC 61 400 dash 32, the new blade o and m standard has in the, in its current draft, it has a section on digital twins. Um, and um, at the last meeting there was a debate as to whether that should be taken out because actually, um, AI, ml, um, all these, um, approaches will just overrun the concept of the traditional digital twin. So, um, I was voting for it to be removed, um, but. Other people didn’t. And so it’s still in the current draft. Yolanda Padron: I am a little bit tired around digital twins at the idea of, like, I’ve seen the title slapped around a lot of things that just aren’t digital twins. And I think that gets even more confusing to a lot of people who are just new to the space or new to the idea that then they, they, they hear digital twin, they have like an idea about it or like, oh, it’s really great, and then they pursue something that just [00:11:00] really isn’t, it’s just a. A monitoring system that they wanted to name something else.  Allen Hall: Yes, that’s it.  Rosemary Barnes: I’ve seen it used well in manufacturing, which is not usually what people are selling it as, but you know, if you have a new composite part, for example, and like a wind turbine blade is a really good example, you design it. And then you can only test it to a certain extent. Um, and you never know exactly what you’ve made, right? And so it’s really hard to kind of relate, like to validate your design tools when not every blade is the same. You know, it’s aiming to be the same. The design is the same every time, but you’re gonna get different results every time you test it. But with some advanced, uh, manufacturing, like my favorite thing to argue with Alan about 3D printing, um, fiber reinforced composites. You can really precisely know exactly what your part looks like all through the structure. You know where every void is. Um, you know where every fiber is and then so you know that exact part. Then you can test that exact part, and you do that with, you know, a dozen of them and you can really [00:12:00] build up a model of what kinds of defects are really, um, you know, doing what to the performance output. And then that can help you to get your quality, um, acceptance to really, like you, you can do the things that matter instead of guessing, oh, okay, yeah, we know that we want this much. Bond line, you can actually know, okay, well like where does that matter? Where doesn’t it? What’s the actual threshold? However, it’s very expensive to do that, and I don’t know that it would make sense for wind turbine blades economically, maybe. Maybe it will one day. I mean, if we can get the quality data that we need, there are big pro quality problems that need to be solved with blades so. I think it’s something to not totally rule out anyway. Matthew Stead: That’s quality control. That’s not a digital twin.  Rosemary Barnes: No, but it is. You have the di you have the make up a digital twin of the, of the part that you’ve made, and then you test it and then you can, um, digitally test the [00:13:00] part that you, the model that you have. So it is a digital twin. Um, it’s just used in a very different way to what digital twins are usually sold as. It’s not at the right level yet for a hundred meter long. Composite wind turbine blade. Um, and also because you would need to destructively test, you know, a, a whole bunch of blades which no one can afford to, to do that.  Yolanda Padron: What if we were to take all the money from like FSAs and stuff that they have to spend, like the OEMs actually have to spend from all of the manufacturing defects from, oh, I tweaked this on this blade type in this. Factory and set it to print and then I tweaked it over here and then I set it to print for like hundreds and hundreds of blades. Um, you know, all of that money spent accumulates too, if we really wanna look at the business case. But eventually, I think maybe it’d be great if it were to work out. I am also.[00:14:00] Hoping  Rosemary Barnes: I, I think it would be a really interesting project to work, and I bet I could. I, I bet that, you know, a good project manager could get, get a positive business case out of it. At the end. One of the problems is that like service, the service department bucket of money is not at all related to the manufacturing bucket of money. Um, so, or the, yeah, the engineering back of the money that, that, that would be a really big problem and make it harder to find a positive business case. But I still think that it’s, um. Yeah, it, there’s a lot of potential there. It would be really interesting project to work on.  Matthew Stead: In terms of the operational phase, I, I think, um, like I said before, the A IML tools. A way more powerful with anomaly detection rather than building a, a fancy digital model, which is not accurate. Um, actually you’re better off looking at the deviations and then the anomalies from what you expect. And I, and there are quite a few people that are doing that, and I, I personally think that’s a way more effective method during the operations and maintenance phase. Rosemary Barnes: But I think that that [00:15:00] would be related. It would be a way to improve what you’re doing there because you said, yeah, digital twin, that’s not. Accurate. So you would need to be accurate. That would be the project to figure out like how you can get accuracy in the right places that you need it. You wouldn’t be able to afford to have accuracy over the entire blade ’cause it’s just way too much data. And then, um, it would help you to figure out like what anoma, what anomalies do we need to look for that are the, the critical ones. I, I think that they would, they would work in partnership. Um, not as two separate things. Can I just plug, because I’m gonna go to China in April and can I just plug that if anyone has any projects, I’ll be there anyway. And um, yeah, so I am sharing the cost of the trip between a few different collaborations and there will be a chance. To, to get me out there to see some manufacturing, et cetera. Would be really excited to go visit some Chinese [00:16:00] manufacturing, some Chinese development. Got a few, few tentative irons in fires at the moment, but would love to have Chinese companies reach out to me and see if we can arrange a collaboration  Allen Hall: as wind energy professionals. Staying informed is crucial, and let’s face it difficult. That’s why the Uptime podcast recommends PES Wind Magazine. PES Wind offers a diverse range of in-depth articles and expert insights that dive into the most pressing issues facing our energy future. Whether you’re an industry veteran or new to wind, PES Wind has the high quality content you need. Don’t miss out. Visit PS wind.com today. It has been a turbulent chapter in offshore wind in America. No doubt about that vineyard wind. The first large scale offshore wind project in the US has faced a crazy difficult road after months of uncertainty, partial construction, and a federally ordered pause. The [00:17:00] project has reached a telling milestone the first. And final shipment of the last blade has departed the port of New Bedford, Massachusetts. And, uh, the blades were just sitting on port for a little while. Uh, Keyside. So this is the last blades or set of blades that’s going out to a turbine. This should sort of wrap it up. I, although I do think there are a couple of blades that may still need some modification updates, something of the sort. But in terms of getting termites out in the water. This should be it. And remember a few months ago, GE and uh, a number of others, vineyard was saying that they’re trying to be done in March. So they’re going to come really close to doing that. And that I know they’re trying to get power all turned on for the site. Because once that happens, it’s really hard for the, uh, the federal government to put any stops on them. I, I guess the question is now, is there any future for offshore wind for [00:18:00]ge now that this is complete and, and it’s kind of off the books, which is what they’ve been trying to do for the last roughly two years, is get it off the books. Matthew Stead: Um, as a positive, I mean. You know, every industry goes through challenges and improve. So I mean, despite all the turmoil, you know, there has to be some good come from it, even though it is been a painful, horrible process. You know, surely there’s some good come from it in terms of improved quality in the future, improved processes, so,  Allen Hall: well, I, I guess that’s the question is are they taking some of these lessons learned and applying them, or are they taking the lessons learned and saying we’re not gonna do that again in, in terms of going down the pathway for offshore wind. Matthew Stead: Well, I think if, uh, if they don’t apply the lessons, that’s sort of, it shows a massive failure of an organization.  Allen Hall: Yeah. It may, I guess it’s a question if it’s a technical failure or a financial failure. Maybe it’s both at the minute until they get everything up and running. But I think the financial side has been. Driving a number of the, of the decisions because the [00:19:00] technical side hasn’t gone all that well.  Matthew Stead: Uh, I think, uh, I think the financial side is an art, which I don’t understand.  Allen Hall: Yeah. Yeah. There’s a lot of moving pieces in financing offshore wind. Now, Vestas has won a, a couple of big. Uh, orders from RWB offshore and Vestus has obviously been in, in some offshore, not at the scale as originally as some of the other OEMs. It does look like the future is bright for Vestus offshore. Is that just gonna continue on that? Vestus is going to invest heavily in offshore and basically dominate that market. Or compete against a a Chinese manufacturer. It doesn’t seem like Siemens is gonna win a lot of offshore contracts off. At least today it doesn’t. You don’t see a lot of noise about that. You see mostly Vestas winning these gigawatt orders. It almost seems inevitable they’re gonna win most of them.  Matthew Stead: Um, I don’t, being long way, way away from where these projects are being made, uh, installed. Um, I don’t have the same sort of insights. [00:20:00] Um, but, um, I mean, obviously yeah, vest, MHI, the previous, um, you know, joint venture with MHI, which especially heavy industries. Um, obviously they’ve come from a, a long pedigree of, um, working offshore, so yeah, I mean, why not? And, um, it seems to be a more of a gradual ramp up, um, and a more orderly, systematic ramp up for offshore. So, yeah. Why, why wouldn’t that work?  Allen Hall: Well, we should hop on the. China discussion because, uh, China’s when turbine makers obviously been trying to build turbines in, in Europe at scale for quite a while now. Uh, and Ying Yang is talking about focusing their efforts on. Germany and they have joined the German Offshore Wind Association BWO. And this is not just a membership cards, uh, that they have subscribed to. It is really like, in a lot of people’s opinion, a strategic signal that Ming Yang intends to compete in the European off.[00:21:00] Market, maybe starting with Germany. Ming Yang was trying to get into Scotland originally, and they were talking about a billion and a half pounds being poured into Scotland to develop factories for offshore wind. Maybe that has come, uh, time has passed and Ming Yang is moving on to Germany. That’s what it reads like to me. Or, or they’re gonna hedge their bets and, and look at both places to see if they can get a foot. Print established in either country.  Matthew Stead: I mean, reputation matters. So you really need to build up a, a footprint. And why would you apply a scatter gun approach? So, I mean, you know, just targeting, you know, one region or, um, you know, makes complete sense to me. So, you know, get, get, get some turbines in the water, get them up and running, get them, get the reliability and the, the reputation, and then, and then go from there. I mean, made complete business sense.  Allen Hall: Well, does that mean that, uh, a mean yang is going to have to lose a little bit of money early on to get some turbines in the water just to demonstrate that they [00:22:00] can do it at scale in Europe? Matthew Stead: I might defer to Rosie, but I would’ve thought they don’t need to, you know, cut costs. I think they’re already cost effective. So you would’ve thought they would just go in, um, with their, their normal product offering and still be successful. Uh, but maybe I’m, I’m on the wrong mark there.  Rosemary Barnes: My understanding is, and I, I don’t know heaps. But my understanding is with Chinese when turbines, that there’s a separate version for the Chinese market, and then if they wanna sell it internationally, then they need to make a new version of it that will pass the IEC, um, standards and the kinds of, you know, certification testing that everybody in those markets is used to. So you’re not always getting, or I don’t think you, I think you’re usually not getting the exact same product. So just because the product exists in China doesn’t mean that it is. Um, without risk in new markets.  Allen Hall: Well, I’m, I’m just curious if ING Yang will have to do a complete IEC certification process because they haven’t done it yet. Uh, is that what you’re saying?  Rosemary Barnes: They do [00:23:00] a, actually a redesign so that they can pass the, um. Certification and then they, yes, they do the whole certification process. However, Mingan hasn’t sold no turbines outside of China. So they have, or it’s not like this is a brand new thing for them that they’ll have to have to, you know, figure out as they go. Um, they’ve, they’ve, you know, I, I, if they haven’t done it for these specific turbines that they’re planning to manufacture in that factory, they’ve at least done it for others and know the process. Um, yeah, and I think we all know it’s not that hard to pass a certification test, so it’s not like a huge obstacle for them. But it will add, it will add cost to the, um, to the process and to the product. Probab probably, you know, there are some design changes that will be needed that will increase the cost of the product. So I don’t think that we’re gonna see, um, you know, Chinese turbines from any, any manufacturer outside of China that are as cheap as the prices that you see within China. Matthew Stead: To be fair though, um, there is a strong, um, Chinese involvement in the IAC committees. So, um, [00:24:00] definitely the, the standards are being used. So, you know, the standards are being used in China, and so I, I don’t think it’s a huge stretch from, you know, the, the domestic product versus the international product. Allen Hall: That wraps up another episode of the Uptime Wind Energy Podcast. If today’s discussion sparked any questions or ideas, we’d love to hear from you. Reach out to us on LinkedIn. Don’t forget to subscribe. So if you never miss an episode, and if you found value in today’s conversation, please leave us a review. It really helps other wind energy professionals discover this show for Rosa, Yolanda, and Matthew. I’m Alan Hall, and we’ll see you here next time on the Uptime Wind Energy Podcast.

durée : 00:04:15 - Les P'tits Bateaux - par : Camille Crosnier - Nombreux sont ceux ayant rêvé de braver le feu dans une combinaison rouge. Maxence, 4 ans est l'un d'eux. Il souhaite donc connaître l'âge requis pour intégrer les rangs des pompiers. - réalisation : Stéphanie Texier, Marjorie Devoucoux - invités : Florence Rabat Lieutenant-colonel de sapeurs-pompiers à Saint-Étienne, vice-présidente de la Fédération des sapeurs-pompiers de France Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

In this episode, we review the Thai GL series Harmony Secret and break down why this show has captured the attention of Thai GL fans and shippers alike.We start with the standout element of the series: the explosive chemistry between the leads. Sonya Saranphat stars as May and Lookmhee Punyapat plays Ai, and together they deliver one of the most compelling dynamics in recent Thai GL. Known to fans as the ship LMSY, their rivals to lovers relationship brings tension, emotional payoff, and plenty of unforgettable moments. We break down how their dynamic develops throughout the series and why their chemistry has made such an impact with viewers.We also highlight one of the most entertaining parts of the show: the side couple Yam and Ge. Their wild and chaotic energy adds a fun layer to the story, and we talk about why we wish the series had given them even more scenes.Another topic we dive into is the soundtrack, including the opening credits theme that quickly became an unskippable OST for fans of the series. From the music to the production choices, we discuss how Harmony Secret creates a memorable viewing experience.If you are a fan of Harmony Secret, a supporter of the LMSY ship, or someone who enjoys thoughtful media analysis of Thai GL series, this episode explores the relationships, performances, music, and storytelling that make the show so much fun to watch.If you want to support us and gain access to bonus content become a Patreon: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BGE Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Wanna talk queer media with us and our friends? Join our Discord: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BGE Discord Link⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠This episode along with all our other episodes are now available on YouTube: Check out the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BGE Channel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠As always, please feel free to reach out to us on all the things. We love hearing from you!Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@biggayenergypod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter(X)      ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@⁠⁠⁠⁠⁠biggayenergypod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Tik Tok      ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@Biggayenergypod⁠⁠⁠⁠⁠Tumblr      ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@⁠⁠⁠⁠⁠biggayenergypod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#HarmonySecret #LMSY #ThaiGL

Wir können alle aufatmen, denn das Schuldendrama hat endlich seinen gebührenden Abschluss gefunden. Der Tribut wurde gezahlt und der Geödtransfer vollzogen. Die nächsten Starbucks Coffees sind erstmal ein Jahr gefühlt for free. Abgesehen davon gibts diese Woche wieder eine Massage Geschichte für euch, die sich im Endeffekt als 3 Stunden soziales Unwohlsein herausstellte und mit einer unzufriedenen Masseurin endete. Und selbstlos wie wir sind, haben wir euch noch eine kleine chinesisch Lernstunde gegeben, damit ihr nicht irgendwann da steht und jemandem random Blowjobs anbietet... Hier findest du alle Infos & exklusive Rabatte unserer Werbepartner: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/podcast_hobbylos⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Hobbylos ist eine Produktion von Spotify Studios. Kontakt: hobbylos@youmgmt.de Learn more about your ad choices. Visit podcastchoices.com/adchoices

Geçtiğimiz perşembe günü Çevre, Şehircilik ve İklim Değişikliği Bakanlığı'nın davetlisi olarak Türkiye'nin COP31 başkanlığı sürecine ilişkin İstanbul'da düzenlenen basın toplantısına katıldım

Operation Epic Fury continues targeting Iran, principally with airpower. Last week, we looked at the air campaign from the planner's perspective. This week, we get the operator's view from former Air Combat Command chief Gen. Mike “Mobile” Holmes. Plus the week's headlines in airpower. Powered by GE!

En este episodio hablamos de los resultados de Grupo IUSA; de la última edición de Forbes con la lista de los billonarios; del crecimiento del mercado de carne seca; de la valuación de Quince; de las descendientes de GE y más.Notas del episodio:06:28 - Grupo IUSA11:44 - billonarios16:37 - carne seca20:02 - Quince26:46 - GE32:49 - operaPrueba Whitepaper 30 días gratisCompra tu gorra o ilustraciones de Whitepaper aquí⁠Escucha nuestro newsletter diario "Whitepaper Hoy" en Spotify⁠

When the CHRO Has Never Worked in Healthcare Featuring Margie Zyble, SVP & Chief Human Resources Officer, UC HealthMargie Zyble came to UC Health by way of GE and a vertical farming startup. That unconventional path is exactly what makes her perspective on healthcare HR worth listening to.

In this episode of #TheShot of #DigitalHealth Therapy, Jim Joyce and I sit down with Carl Bradford Byers

In this episode of Corporate Finance Explained on FinPod, we examine how financial targets shape behavior inside organizations and why targets are never just neutral planning tools. Revenue goals, margin thresholds, return targets, and quarterly quotas may look like objective numbers on a spreadsheet, but in practice they influence hiring, investment, risk-taking, and the day-to-day decisions that define a company's operating culture.This episode breaks down the hidden mechanics behind target design and shows how poorly structured targets can create dangerous incentives. When financial expectations become detached from operational reality, they can drive short-term behavior that harms long-term value. When they are designed well, they create discipline, reinforce capital efficiency, and support sustainable performance over time.In this episode, we cover:

In this episode of the Medical Sales Podcast, host Samuel Adeyinka sits down with Marie Robert, a GE Healthcare product sales specialist, to break down what it's really like selling capital medical equipment in one of the most competitive markets in the world. Marie shares how she entered the industry through GE's Commercial Leadership Program, what a day in the life of a New York City medical sales rep looks like, and how selling anesthesia machines requires deep hospital relationships, strategic thinking, and constant collaboration with physicians, procurement teams, and biomedical engineers. She also discusses the realities of working in a large corporate environment, the future of medical sales in an AI driven world, and the mindset, discipline, and resilience needed to succeed in this fast paced and highly competitive industry. Connect with Marie Robert: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »

Part 2 of 2 | Continued from: Continuous Improvement Leadership: Women's Career Guide 2026Executive SummaryWomen leaders continuous improvement culture succeeds or fails based on one variable: the leader's personal commitment. Olaf Boettger's 27-year framework reveals the CEO's 90-day launch plan, two fatal CI mistakes, women's natural CI advantage, and the 10-minute personal Kaizen practice that compounds career results starting today.Quick Takeaways70% of CI initiatives fail — almost always due to leader behavior, not methodology (Olaf Boettger, 27 years P&G/Danaher)Women leaders continuous improvement culture succeeds because women's natural humility and collaborative style align with CI requirementsThe CEO's first 90 days: Gemba ? Top-10 Problem List ? 5 Whys ? Impact-Effort Matrix ? Daily HuddlesPersonal Kaizen takes less than 10 minutes per day and starts compounding career results immediatelyLaid-off women can apply CI directly to job search — turning a demoralizing process into a systematic, controllable oneIn Part 1 of this conversation, Olaf Boettger revealed the foundations of women leaders continuous improvement culture — Kaizen philosophy, Gemba principles, and the three capabilities that make it work: courage, humility, and discipline. But knowing the philosophy is not the same as executing it.Most organizations have heard of Kaizen. Most have tried it. Most have failed.According to Olaf, who spent 27 years at Procter & Gamble and Danaher mastering this system, the failure is rarely about the methodology. It is almost always about the leader.In Part 2 of our Women's Leadership Success Podcast interview, Olaf reveals exactly what a successful women leaders continuous improvement culture launch looks like — the CEO's first 90 days, the two fatal mistakes that kill every initiative, why women bring a genuinely underappreciated competitive advantage to this work, and the personal Kaizen practice that takes less than 10 minutes a day and starts compounding results immediately.As an executive coach with over 30 years of experience (MA, MFT, PCC) and host of a podcast ranked in the top 1.5% globally with over 750,000 downloads, I have seen this framework transform the careers of women who stopped waiting to be recognized and started building systems that made them impossible to overlook. Building a women leaders continuous improvement culture is not only a leadership strategy — it is a career survival strategy in 2026.Ready to make yourself the standout candidate in 2026's competitive market?Download our FREE Leadership Branding Blueprint Accelerator and discover:The exact 5-step system to position yourself as indispensable (not just competent)How to document CI results in a format that gets you promoted 3x fasterThe personal achievement tracker that turns invisible work into visible impactScripts for self-advocacy conversations that feel natural, not pushyDOWNLOAD FREE — womensleadershipsuccess.com/blueprintThe CEO's First 90 Days: Your Continuous Improvement Culture Launch PlanIf you are stepping into a new leadership role — or finally ready to build a women leaders continuous improvement culture in your existing organization — the first 90 days set everything. Olaf's approach is structured around a deceptively simple insight: the problems you can solve are already visible if you are willing to go look at them.Step 1: Go to Gemba — The Real Place (Days 1–30)Gemba is the Japanese term for the real place — where the work actually happens. For a CEO or senior leader, Gemba might mean riding along with a salesperson, observing operations on a floor, sitting with engineers reviewing prototypes, or speaking directly with customers about how they use your product.This is not a listening tour. It is a fact-gathering mission. The gap between what leadership believes is happening and what is actually happening is, in most organizations, enormous. The only way to close that gap is to go see for yourself.For women building a women leaders continuous improvement culture, this Gemba-first approach is especially powerful: it signals humility and curiosity before authority — the exact combination that earns trust fast in new organizations.Step 2: Build Your Top-10 Problem List (Days 15–30)After Gemba, the next move is prioritization. A former Danaher colleague of Olaf's — who became CEO of a large Anglo-American corporation — used exactly this method: he created a numbered top-10 problem list and began working through it methodically with his teams.The discipline here is critical. You are not solving all problems. You are sequencing them. Problem 1 gets your full attention and resources until it is resolved. Then Problem 2. Then Problem 3. This focus prevents the scattered, multi-initiative paralysis that kills most CI attempts before they produce results.Step 3: Apply the 5 Whys to Find Root Causes (Days 20–60)Once you have your prioritized list, the next step is diagnosis. Olaf uses the 5 Whys — a Toyota-originated technique where you ask 'why does this problem exist?' and then ask 'why?' to each answer, five levels deep. By the fifth 'why,' you are nearly always at the systemic root cause rather than a surface symptom.The difference is critical. Treating symptoms produces temporary fixes. Addressing root causes produces permanent improvement. This is why organizations that chase the first obvious solution — like a $50 million ERP system — often spend enormous resources only to discover the original problem persists.Step 4: Use the Impact-Effort Matrix to Sequence Solutions (Days 30–60)Not all solutions are equal. Olaf teaches leaders to categorize every potential solution across two dimensions: impact (does it actually solve the problem?) and effort (how much time, money, and energy does it require?).Solution CategoryPriority Action? High Impact + Low EffortDo these FIRST — quick wins that build momentum and credibility? High Impact + High EffortPlan carefully — these are your strategic projects? Low Impact + Low EffortDo only if capacity allows — don't let these consume bandwidth? Low Impact + High EffortEliminate — these drain your CI culture before it startsStep 5: Run Daily Red/Green Huddles as Your Standard Management Meeting (Days 1–90)As described in Part 1, the 15-minute daily red/green huddle is not a CI activity added on top of normal business. It IS the management meeting. Red means a problem is identified and being addressed. Green means performance is on track. Run without exception every day, it signals that the improvement culture is real — not a program that fades at the next crisis.What Your Organization Sees by Day 90When you execute this plan, three things happen simultaneously: your team sees you are committed enough to observe their actual work; they see the organization's most painful problems being addressed systematically; and they begin to internalize what a good solution looks like. This is how women leaders continuous improvement culture takes root — through behavior modeling, not value announcements.The 2 Fatal Mistakes That Kill Continuous Improvement InitiativesOlaf estimates there is a graveyard of failed CI initiatives in nearly every large organization. The causes are almost never about the methodology. Here are the two patterns he sees repeatedly — and what women leaders can do differently.Fatal Mistake #1: The Leader Who Wants Results Without ChangingIn German, there is a phrase for this: 'Wash my fur, but don't make me wet.' The leader wants the outcomes of CI — better numbers, more efficient teams, fewer crises — but is unwilling to personally change how they operate. They hire consultants, launch programs, run trainings. And then they return to their previous behavior.This is fatal because culture follows behavior, not announcements. If the CEO does not go to Gemba, the SVP will not go to Gemba. If the SVP does not go, the VP will not go. By the time the directive reaches managers who are supposed to implement CI, it has been diluted into a program that nobody owns.For women leaders specifically: the antidote is your natural advantage — the willingness to be publicly humble, to admit what you do not know, and to go see before you decide. A women leaders continuous improvement culture that the top leader personally models is one that spreads without a mandate.Fatal Mistake #2: Treating CI as a Separate ActivityThe second pattern is more subtle but equally deadly: organizations that run CI as a parallel track alongside their 'normal' business. Friday afternoon training. Quarterly workshops. A dedicated CI team that other leaders do not engage with.This is the wrong model entirely. At Toyota, Danaher, GE, and every organization where CI works long-term, continuous improvement is not something you do in addition to running the business. It IS how you run the business. The 15-minute daily red/green huddle is not a CI activity — it is the operational meeting. The improvement system and the management system are the same system.The practical implication: if your organization has a CI initiative that exists separately from how work is actually managed, advocate for integrating the two. That single structural change will determine whether your women leaders continuous improvement culture produces lasting results or joins the graveyard.Why Women Leaders Build Continuous Improvement Culture BetterOne of the most powerful moments in our conversation came when I asked Olaf directly: do women bring unique strengths to continuous improvement culture?His answer was unequivocal — and grounded in 27 years of observing what actually works in organizations around the world."There is a lot less ego involved in a lot of women I've worked with. And if we look at the three capabilities for successful continuous improvement — courage, humility, and discipline — I've seen women bring more to the table, especially on the humility side. Being more open to say: let's bring others in,

Enjoyed this episode or the podcast in general? Send me a text message:A freezing South Dakota night, wrenches crusted in frost, and a bomber built to bend physics and distance to its will. We take you from the flight line to the target area to unpack how the B‑1B Lancer—once a controversial Cold War project—became America's relentless conventional strike hammer during Operation Epic Fury.We break down the numbers that matter: thrust‑to‑weight at max takeoff, wing loading versus runway length, and why variable‑sweep geometry lets a half‑million‑pound aircraft leap from ice‑cold concrete, climb, and then sprint supersonic. You'll hear how GE's F101 engines survive turbine inlet temperatures above 2,500°F, why the KC‑135 and KC‑46 tanker bridge is the real backbone of global reach, and how a fly‑by‑wire boom delivering 1,200 gallons per minute turns fuel into firepower. Then we dive into penetration tactics: sweeping to 67.5 degrees for dash, riding the deck at near‑Mach to hide in terrain, and using S‑ducts and internal design to slash radar returns. The secret sauce? A Structural Mode Control System that actively damps brutal low‑level vibrations so crews can fight and the airframe can live.Inside the bays, it gets even more serious. Three rotary launchers upgraded with BRU‑56 ejectors let the Lancer carry an astonishing 24 JASSM‑ER cruise missiles, each a stealthy, 600‑plus‑mile punch against hardened targets. We trace the targeting workflow from Link‑16 tasking to programmed coordinates to that violent door snap and clean eject that sends missiles sliding into the slipstream—over and over—until command nodes and launch sites go dark. Along the way, we honor the human element: maintainers from the 28th Bomb Wing turning jets in subzero wind, crews sitting ejection seats for 34 hours, and tanker teams flying in radio silence to hold the bridge across oceans.If you care about airpower, engineering, and the hard math of global strike, this deep dive connects history, physics, and logistics into a single, razor‑sharp picture of how modern bombing actually works. Subscribe, share this episode with a friend who loves aviation, and leave a review with the one moment that shocked you most.Support the showTo help support this podcast and become a PilotPhotog ProCast member: https://www.buzzsprout.com/1555784/supportIf you enjoy this episode, subscribe to this podcast, you can find links to most podcast streaming services here: PilotPhotog Podcast (buzzsprout.com) Sign up for the free weekly newsletter Hangar Flyingwith Tog here: https://hangarflyingwithtog.com You can check out my YouTube channel for many videos on fighter planes here: https://youtube.com/c/PilotPhotog If you'd like to support this podcast via Patreon: https://www.patreon.com/PilotPhotog And finally, you can follow me on Twitter here: https://twitter.com/pilotphotog

MAR. 5, 2026It came to pass-not stay."It came to pass." Ge 4:3 NKJVThere is a little phrase repeated 436 times in the Bible: "It came to pass." Whatever trial you are going through today, remind yourself, "It came to pass-not stay." If the fulfillment of the vision God gave you seems to be taking longer than you thought, remind yourself "it will come to pass!" In his biography, God in My Corner, the two-time world heavyweight champion George Foreman tells a story about an elderly woman who was asked her favorite Scripture verse. She replied: "And it came to pass." She explained why: "I know that whenever a trial comes, it doesn't come to stay; it comes—to pass." And the Scripture on the flipside of this coin reads:"Being confident of this, that he who began a good work in you will carry it on to completion" (Php 1:6 NIV). In other words, He will bring it to pass! Either way, God always finishes what He starts. "The vision is yet for an appointed time… Though it tarries, wait for it; because it will surely come [to pass]" (Hab 2:3 NKJV). Battling an illness that threatened his life, and enemies who wanted to take his throne, David turned to the Lord for help. And God didn't disappoint him. Read these two Scriptures and stand on them: "Weeping may last through the night, but joy comes with the morning" (Ps 30:5 NLT). "You have turned my mourning into joyful dancing. You have taken away my clothes of mourning and clothed me with joy, that I might sing praises to you and not be silent. O Lord my God, I will give you thanks forever!" (Ps 30:11-12 NLT).It came to pass-not stay God always finishes what He starts.Share This DevotionalSend a textSupport the showChanging Lives | Building Strong Family | Impacting Our Community For Jesus Christ!

Airpower is in action, with the U.S./Israeli Operation Epic Fury targeting Iran, and many countries defending themselves from Iranian retaliation. The architect of the Desert Storm air campaign, retired Lieutenant General David Deptula, joins us to look at the operation so far, how long it will last, how to put together an air campaign, friendly fire, and much more. Plus headlines. All powered by GE!

Larry Kesslin spent much of his life chasing success. After leaving corporate America at 29, he built a successful career as an entrepreneur advising business owners across the country.   By most standards, he had freedom, financial stability, and the life he once thought he wanted. Yet something was still missing. In this episode, Larry shares the moments that changed how he sees success.    A volunteer trip in Aspen and a later time in rural Uganda made him question the life he had built. Over time, he realized that chasing success was different from living with purpose.   In this episode:   How financial insecurity in childhood shaped his drive to succeed The moment at GE that led him to leave corporate life What he learned about happiness while traveling in Africa The difference between success and significance How our belief systems are formed and why they can be unlearned Why aging gives us the chance to question identity   Resources: Larry on LinkedIn  5-Dots Joy Molecule

Send a textThe Mediterranean diet has become medical gospel—promoted by diabetes organizations, heart health foundations, and doctors worldwide. But when I looked at the actual evidence, I found something shocking: the one major study proving its benefits was so flawed it had to be retracted. And when NICE updated their cardiovascular disease guidelines in 2023, they admitted there was "no available evidence" comparing dietary interventions to normal diets, so they made recommendations based on "clinical experience and expert opinion" instead. In this episode, I expose how decades of lifestyle advice rest on a foundation of observational studies that can't prove causation, one retracted trial, and guidelines that openly admit the evidence doesn't exist. I explore why we ignored Japan despite identical findings, how the Mediterranean diet reflects Eurocentric superiority rather than scientific rigor, and why telling Black, brown, and indigenous communities to abandon their cultural foods for olive oil is racist as f*ck. The evidence doesn't support what we're being told and it's time we started demanding better.Ge, Long, Behnam Sadeghirad, Geoff D. C. Ball, et al. ‘Comparison of Dietary Macronutrient Patterns of 14 Popular Named Dietary Programmes for Weight and Cardiovascular Risk Factor Reduction in Adults: Systematic Review and Network Meta-Analysis of Randomised Trials'. The BMJ 369 (April 2020): m696. https://doi.org/10.1136/bmj.m696.Got a question for the next podcast? Let me know! Connect With Me WEEKLY NEWSLETTER: Get a free script when you sign up THE WEIGHTING ROOM: Community with a neurodivergent flavour. **BOOK CLUB** exclusive to Weighting Room members. CONSULTATION: For the ultimate transformation in your healthcare journey MASTERCLASS LIBRARY: Become an expert in your condition and the weight inclusive ways to manage it FREE GUIDES:Evidence-based, not diet nonsense Find me on Instagram, YouTube, and LinkedIn.

＜目次＞(0:00) エル・セグンドにいるMihoさんとArbor Energyの紹介(5:35) 調布からの生活で感じた危機感(8:19) グリーンカードの抽選に当たるミラクル(13:00) アメリカに住むために親を説得させるためのプレゼン(14:11) まずは住む場所から探す(15:43) NOVA3級の英語でどうアメリカで生活したのか？(19:16) グリークラブに入れた良さ、ホームシックに1度しかならなかった(23:43) コミュニティカレッジから南カリフォルニア大学まで(26:45) フライトアテンダントになる夢がエンジニアになる夢へ進化(29:46) 大学のロケットクラブで何をするのか(36:44) GEに入る時のハッスル、GE Japanでの経験(41:20) 日本国籍を無くしてしまったMihoさん(44:34) 5万人いるGEから少人数のスタートアップへ(47:28) SpaceXの対抗的なカルチャー(50:21) Rivian時代でのコロナのサプライチェーンの大変さ(55:25) Arbor Energyにジョインした理由(59:33) 後編ではエル・セグンドやSpaceXマフィア話！Miho Onuki Bealhttps://www.linkedin.com/in/mihoonuki＜About Off Topic＞Podcast:Apple - https://apple.co/2UZCQwzSpotify - https://spoti.fi/2JakzKmOff Topic Clubhttps://note.com/offtopic/membershipX - https://twitter.com/OffTopicJP草野ミキ:https://twitter.com/mikikusanohttps://www.instagram.com/mikikusano宮武テツロー: https://twitter.com/tmiyatake1

Geçtiğimiz yıl Tanıl Bora ile gerçekleştirdiğimiz “Antroposen'de Türkiye: Çevre Düşüncesi, Bellek ve Yeni Cereyanlar” başlıklı söyleşiye yeniden dönüyor; Türkiye'de çevre düşüncesinin bağımsız bir “cereyan” olup olamayacağını, ekolojizm ile çevrecilik arasındaki farkları ve Antroposen çağında düşüncenin nasıl yeni bir zemine kavuşabileceğini tartışıyoruz. 

Mike Sufficool shares how persistence, grit, and an unwavering commitment to others transformed early career struggles into a decades-long story of growth, leadership, and legacy. GE-8786986.1 (2/26) (Exp.2/30)

Forskning visar hur man skulle kunna förtäta städer utan att buller och föroreningar ökar. Lyssna på alla avsnitt i Sveriges Radios app. Städerna växer och många städer brottas med förtätningsprojekt. Hur ska man kunna bygga fler bostäder utan att nagga grönområden i kanten, bugga för nära bilvägar eller andra sätt som kan öka ohälsan i staden.Nu visar ett projekt från Lunds universitet, att det kan gå om man prioriterar ner biltrafiken och i stället satsar mer på kollektivtrafik, cykling och gångtrafik. Och bygger på höjden för att inte ta för mycket av det gröna. I projektet fick forskarna göra en sorts drömscenarier av några bostadsområden där det redan fanns långt gångna planer på hur områdena ska kunna förtätas. Och de kunde i sina beräkningar bl a visa på tydliga minskningar i hur många som skulle bli störda av buller, och sova dåligt på nätterna, om man i stället byggde enligt deras idéer.Medverkande: Ebba Malmqvist, Anna Boudin och Kristoffer Mattisson, Lunds universitet Reporter: Lena Nordlundlena.nordlund@sr.seProducent: Lars Broströmlars.brostrom@sr.se

Ty Farmer, senior director of Corporate Safety at Dycom Industries, Inc. could have let being placed on a performance improvement plan (PIP) early in his career derail him completely. Instead, he turned a difficult moment into a powerful learning experience and an opportunity for growth. Ty's military background led him to his first role at General Electric (GE), where he was quickly thrown into the fire as a regional EHS manager for the United States, Mexico, and Canada. Rather than shutting down in the face of early challenges, Ty leaned into his experiences, using them as opportunities to reflect and grow. After more than a decade at GE, he moved on to a new role where he built an organization's safety program completely from the ground up. In this episode of My Big Safety Challenge, Ty shares why building genuine connections across an organization—from the brand-new employee to the c-suite executive—is essential to creating a strong safety culture. He also discusses the importance of a glass-half-full mindset, offers practical insight on gaining leadership buy-in, and explains why it's a strength, not a weakness, to ask for help.

Jeff is the President and Majority Shareholder of Schaal Glass Company and we share a conversation that is as much about leadership as it is about loyalty and legacy. Jeff's enthusiasm for Cathedral Prep is unmistakable! As a Prep alum, husband to aVilla Maria Academy graduate (Lora Kelly Johnson ‘04VMA), father of a current Prep junior, and committed donor to the school, his connection to Prep & Villa isn't just nostalgic, it's active, intentional, and generational. Throughout the episode, Jeff shares leadership wisdom shaped by corporate experience at GE, advanced studies in business and supply chain management, and now leading a 100-year-old family company. We talk about what it takes to steward a legacy organization, how to build a disciplined and people-centered culture, and why investing in the institutions that formed you matters. His perspective on leadership, accountability, and long-term thinking makes this an impactful conversation. If you care about business, management, faith, family, and what it means to lead with purpose then this episode delivers. Jeff brings insight, humility, and a deep love for Prep to every part of the conversation!

Η καθημερινότητα της φροντίδας στη δουλειά: Το παράδειγμα ενός μικρού οργανισμού.Για ποιον λόγο προκύπτει η ανάγκη για εξατομικευμένα υβριδικά μοντέλα εργασίας με ευελιξία στο ωράριο, και πώς αυτά μπορούν να συμβάλουν στην προσωπική εξέλιξη και ανάπτυξη των εργαζομένων;Στο νέο επεισόδιο του WHEN on Topic, η Πηνελόπη Θεοδωρακάκου συνομιλεί με τον Ανέστη Μποζογλανιάν, συνιδρυτή του οργανισμου “Πρώτα το παιδί” ενός μικρού οργανισμού που δείχνει στην πράξη πώς η φροντίδα μπορεί να γίνει καθημερινή επιλογή και όχι απλώς μια ωραία ιδέα.Μαζί εξερευνούμε με ποιο τρόπο μπορούμε να δημιουργήσουμε ένα ευέλικτο, εξατομικευμένο υβριδικό μοντέλο εργασίας και να διαμοιράσουμε τις αρμοδιότητες σε περιόδους ανάγκης, ώστε να δημιουργήσουμε ένα εργασιακό περιβάλλον που βασίζεται στην εμπιστοσύνη, τη συνεργασία και το σεβασμό στις πραγματικές ανάγκες των εργαζομένων.Στο 10ο επεισόδιο της σειράς του WHEN on Topic, το οποίο υλοποιείται στο πλαίσιο του έργου CAREdiZO, θέτουμε καίριες ερωτήσεις: Ποια προβλήματα δημιουργούν την ανάγκη για καθιέρωση και εφαρμογή υβριδικών μοντέλων εργασίας; Ποιες διαδικασίες χρειάζεται να εφαρμοστούν ώστε η ομάδα να είναι και να παραμένει λειτουργική, και οι εργαζόμενοι να μπορούν να διεκπεραιώνουν έγκαιρα τα εργασιακά τους καθήκοντα; Ποιες προκλήσεις μπορεί να προκύψουν από την εφαρμογή τέτοιων πολιτικών και πώς μπορούν να αντιμετωπιστούν;Η εμπιστοσύνη μπορεί να διατηρήσει την ισορροπία και το καλό κλίμα μέσα σε έναν οργανισμό; Πόσο μπορεί να βοηθήσει η ανοιχτή επικοινωνία μεταξύ των εργαζομένων;Πώς αυτή η ευελιξία αλλάζει την κουλτούρα και την καθημερινότητα μιας ομάδας;Μέσα από το παράδειγμα ενός μικρού οργανισμού, συζητάμε με ποιο τρόπο η φροντίδα μπορεί να γίνει οδηγός για πιο υγιή, πιο συμπεριληπτικά και πιο βιώσιμα εργασιακά μοντέλα.Καλή ακρόαση!Το έργο CAREdiZO υλοποιείται στο πλαίσιο του προγράμματος CERV της Ευρωπαϊκής Επιτροπής, με τη συνεργασία των οργανισμών challedu (Greece), WHEN (Greece), MOTERU INFORMACIJOS CENTRAS (Lithuania), NATSIONALNA MREZHA ZA BIZNES RAZVITIE (Bulgaria), Mediterranean Institute of Gender Studies (Cyprus). Χρηματοδοτείται από την Ευρωπαϊκή Ένωση. Οι απόψεις και οι γνώμες που εκφράζονται είναι, ωστόσο, μόνο των συγγραφέων και δεν αντικατοπτρίζουν απαραίτητα εκείνες της Ευρωπαϊκής Επιτροπής-ΕΕ. Ούτε η Ευρωπαϊκή Ένωση ούτε η Ευρωπαϊκή Επιτροπή φέρουν ευθύνη γι' αυτές.Κωδικός έργου: 101191047 — CAREdiZO — CERV-2024-GE

Emin ve Ömer bu bölümde, baba olmanın onları nasıl değiştirdiğini ve en çok neye şaşırdıklarını konuşuyor. Baba olmak düşündükleri gibi miydi? Yoksa onları hiç beklemedikleri bir şekilde mi dönüştürdü? Hazırsanız, iki taze babadan samimi ve içten bir bölüm sizi bekliyor. Interactive Transcript and Vocab Helper Support Easy Turkish and get interactive transcripts and live vocabulary for all our episodes: easyturkish.fm/membership Show Notes Sponsor Find your ideal Turkish teacher on italki: https://go.italki.com/turkish2 Use the code EASYTURKISH2026 for 5€ off on your first lesson (of at least 10€) Transcript Intro Emin: [0:15] Herkese merhaba. Easy Turkish Podcast'in yeni bölümüne hepiniz hoş geldiniz. Ben Emin. Bugünkü bölümümüzde Ömer'le beraberiz. Nasılsın Ömer? Ömer: [0:24] Teşekkür ederim Emin. İyiyim. Sen nasılsın? Emin: [0:27] Ben de iyiyim. Nasıl gidiyor ramazan? Ömer: [0:29] Çok şükür bir haftayı devirdik. %23'lere tekabül ediyor. Yaptığım hesaplamalar neticesinde bu sonuca ulaştım. Emin: [0:36] Evet. Ömer: [0:37] Güzel gidiyor. Geçen hafta konuşmuştuk. Kış ramazanı, yaz ramazanından sonra çıtır geliyor. Sadece son saatlerde bir böyle acıkma falan hissediyorum. Güzel. Ben memnunum ramazandan. Sen? Emin: [0:49] Evet ben de. Bundan önceki ramazanlar hep böyle baş ağrısı, açlık, susuzluk ekseninde geçerdi. Bu seneki ramazan çok daha rahat geçiyor. Tabii bunda ramazanın kışa denk gelmesinin de çok büyük bir payı var. Ömer: [1:02] Evet, evet. Tabii ki. Çünkü günler uzun olunca uzun oruç, kısa olunca kısa oruç tutuluyor. Ve dediğin gibi kışın çok daha rahat. Dışarıda olduğumuz zamansarf ettiğimiz efor daha az oluyor, soğuk havalarda. Sıcak havalarda daha bunaltıcı ve su kaybı meydana geliyor. Kış ramazanı iyidir abi. Ben şu an memnunum. Yıllar süren yaz ramazanından sonra şu an hâlimden memnunum. Emin: [1:25] Böyle emekli olacağımız zamana da böyle yaz ramazanı olur. Orada da bir emekli oluruz. Çok güzel sıyrılmış oluruz. Ömer: [1:32] Aynen ama öğrencilikte de geçen hafta konuştuk herhâlde bunu. Yaz ramazanı başkaydı şimdi o... Emin: [1:37] Evet evet. Ömer: [1:38] Sahura kadar çöplemeler falan başkaydı yani. Emin: [1:40] Aynen öyle. Evet. Taze babamız Ömer. Nasıl gidiyor? Baba olmak: Teoride her şeyi biliyorduk, ya pratikte? Ömer: [1:47] Valla nasıl gidiyor Emin'ciğim... İyi gidiyor çok şükür. Olağan. Yani en azından bir sağlık problemimiz yok çok şükür vesaire... Bunlar insanı çok rahatlatan şeyler. Çünkü kendini ifade edemeyen bir canlı ile karşı karşıyayız. Hani ağladığı zaman aç da olabilir, altı ıslak da olabilir. Gazı da olabilir, başka bir problemi de olabilir. Dolayısıyla şu an herhangi bir sağlık problemiyle vesaire karşılaşmadığımız için memnunuz. Ama, nasıl diyeyim? Çok olumlu duygular yaşatan bir şey insana. Bir yandan da gerginlik ve korku da veriyor bence. Çünkü o küçücük şey, yani onun sorumluluğu bazen psikolojik olarak insanın gerçekten dirayetli olmasını gerektiriyor ve gerektirecek gibi. Yani biz daha... Hani ben en azından yirmi gündür bunu yaşıyorum ama ileride de bu duygunun kaybolacağını çok zannetmiyorum. Onun için böyle bir korku, bir gerginlik de var üzerimde. Emin: [2:39] Evet ben de yaklaşık yüz yirmi gündür yaşıyorum bu hissi. Support Easy Turkish and get interactive transcripts and live vocabulary for all our episodes: easyturkish.fm/membership

¿Problemas de adicción al #alcohol, #drogas…? ☎️ 915 630 447 ¡LLAMANOS 24H! https://bienestar.neurosalus.com/ Solicita ahora mismo información sobre tratamientos de desintoxicación, precios, disponibilidad de plazas… HA SIDO POSIBLE CREAR EL PROGRAMA “LA REUNIÓN SECRETA” GRACIAS A TU AYUDA COMO GUARDIÁN MECENAS. ***** HAZTE MECENAS EN https://www.patreon.com/lareunionsecreta Esta noche vive un nuevo directo de #LaReuniónSecreta​ desde la 22:00​ hora española. Te decimos lo que nadie dice: sin anestesia y sin edulcorantes. ¡La Reunión Secreta somos todos! No se lo digas a nadie… ¡PÁSALO! CARLITOS TÍNEZ https://www.youtube.com/channel/UC0eeuxpQ70z-Pe0rHhOq9Fg Conexiones en directo con: - Roberto Vaquero (Escritor. Geógrafo e historiador. PML(RC). Presidente del Frente Obrero) - ️ Dr. Guillermo Rocafort (Doctor en Ciencias Económicas por la Universidad San Pablo. Profesor de Economía Pública y Economía de la Empresa en la Universidad Carlos III de Madrid. Profesor del Departamento de Derecho Económico y Social de la Universidad Pontificia Comillas. Abogado) - Andrés Chaves (Periodista. Doctor en Ciencias de la Información por la Universidad Complutense de Madrid) - ️ Federico Bossi (Abogado) Con el equipo habitual de La Reunión Secreta: Dr. José Miguel Gaona, Joan Miquel MJ, Carlos Martínez, Lourdes Martínez, Marta Vim, Olga Ralló, Luna de María, Tatiana y Piluca. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ SÍGUENOS EN REDES Twitter: https://twitter.com/lrsecreta Instagram: https://www.instagram.com/lareunionsecreta/ Facebook: https://www.facebook.com/LRsecreta REDES SOCIALES DEL EQUIPO | DR. JOSÉ MIGUEL GAONA | - https://twitter.com/doctorgaona | DIRECTOR | - Joan Miquel MJ - https://www.instagram.com/official_joan_miquel_mj/ | PRODUCTORA | - Lourdes Martínez - https://twitter.com/chicadelaradio | AYUDANTE DE DIRECCIÓN | - Olga Ralló - https://twitter.com/olgarallo | AYUDANTE DE PRODUCCIÓN | - Carlos Martínez - https://twitter.com/Carlitos_Tinez

With the possible loss of a third HAL Tejas in Gujarat, the delayed response from authorities, and the controversy that has followed, renewed scrutiny is now on India's indigenous fighter programme. Questions are mounting: Has the IAF really lost another Tejas? Why the delay in official communication? And what does this mean for the Mark 1A rollout? In this episode of In Our Defence, host Dev Goswami and national security expert Sandeep Unnithan discuss the controversy, the difference between Mark 1 and Mark 1A and the future of India's indigenous fighter program. The two discuss: * Why the IAF hasn't fully accepted the Mark 1A yet * The GE 404 and 414 engine bottleneck * Indigenous content — how Indian is Tejas really? * The HAL–IAF dynamic and the larger structural silos * Why fighter squadron anxiety is shaping procurement decisions Tune in! Produced by Taniya Dutta

Impact of Feedback: When employees believe their feedback is actually used to make improvements, they are 37% less likely to look for a new job. Pew Research Center On average, engaged employees see a 20% individual performance improvement and an 87% reduction in the desire to leave.   A  2024 research Survey with The Harris Poll found that managers play a critical role in moving employees from burned out and checked out to thriving. For employees who say they are thriving, the top indicator is a manager who is "invested in their success." Employee thriving is driven by three key drivers:   Stephen Baer is the Co-Founder and Managing Partner of Engagency, a firm built on his core belief that human engagement is the engine of business performance. He leads a team of behavioral experts who help organizations build meaningful, measurable connections with their workforce and customers. With a 30-year career focused on the science of connection, motivation, and activation, Stephen brings a rare blend of behavioral insight, creativity, and operational discipline. He previously co-founded and led The Game Agency, a learning and engagement company acquired by ELB Learning, and held sales and marketing leadership roles at Atari and General Electric, where he was a Six Sigma Black Belt Certified and a recipient of GE's Global Marketing Excellence Award. Stephen has served on the Board of ELB Learning and the Advisory Board of the Life Sciences Trainers & Educators Network (LTEN), and was a contributing writer for the Forbes Human Resources Council for six years, sharing insights on engagement and organizational growth. The author of the book, "Stickology: How to Build Unbreakable Connections with Employees and Customers for Life," and two children's books (Catastrophe in the City and The Doghouse), Stephen holds a BA from Oberlin College and an MBA from Columbia University.      For more information: https://stephenbaer.com/ Get the book: https://www.amazon.ca/Stickology-Unbreakable-Connections-Employees-Customers/dp/9699592532. Learn more about your ad choices. Visit megaphone.fm/adchoices

Estamos ante un umbral histórico y es momento de trazar tu mapa personal para navegar la incertidumbre. En este episodio, dejamos atrás el miedo para enfocarnos en las oportunidades reales que trae el cambio planetario entre 2026 y 2030. No es algo que te sucede, es algo que tú creas a través de tu transformación interna.He diseñado una hoja de ruta basada en lo que realmente funciona para mantener la paz mental y la soberanía personal en tiempos de crisis. Hoy te voy a hablar de 6 pilares fundamentales para evolucionar sin resistencia: desde entender las siete realidades del cambio y la importancia de la gestión emocional, hasta preparar tu cuerpo como el vehículo de la nueva humanidad.Vamos a hablar con honestidad sobre el crecimiento espiritual, el desarrollo de la intuición y un punto clave: habilidades de subsistencia y adaptación rápida para alcanzar la verdadera libertad. Este es el momento de vivir en el presente con herramientas reales para construir el futuro que deseas. ¡Prepara papel y lápiz! Hoy elegimos el norte que nos guía hacia un bienestar integral. Guarda este episodio, será tu guía esencial de aquí al 2030.EN ESTE EPISODIOFamiliarizarse con las 7 realidades del cambio.Crear espacios de trabajo interno que te apoyen.Trabajar en tus emocionesPreparar y apoyar el cuerpoDesarrollar la intuiciónAdquirir habilidades comunitarias y de subsistencia. Inscríbete y DESCARGA tu regalo Descubre tu ser intuitivo AQUÍ. ME ENCUENTRAS ENInstagram Web Alkimia Web Marcela Hede YouTube Facebook

We attended the Air and Space Forces Association Warfare Symposium so you didn't have to. General Atomics Aeronautical Systems president Dave Alexander gives us the latest on a slew of programs. We review the event and Air and Space Forces magazine editor Tobias Naegele and Mitchell Institute Dean David Deptula add their views. Plus a headline or two. All powered by GE!

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic gastroesophageal cancer. They share first-line and subsequent-line recommendations for both gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma based on actionable biomarkers including PD-L1 expression, MMR and/or MSI, CLDN18.2 expression, and HER2 status. They note the importance of the algorithms and tables in the guidelines that provide visual illustrations and quick reference guides of the evidence-based recommendations. They also comment on ongoing and recently presented trials that may impact future guidelines in this space. Read the full guideline, "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update" at www.asco.org/gastrointestinal-cancer-guidelines" TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/gastrointestinal-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02958      Timestamps ·       00:00 – 02:15 Introduction and Overview ·       02:16 - 08:20 First-line treatment for patients with pMMR/MSS, HER2-negative gastroesophageal adenocarcinoma ·       08:21 –10:29 First-line treatment for patients with pMMR/MSS, HER2-positive gastroesophageal adenocarcinoma ·       10:30 – 14:39 First-line treatment for patients with dMMR/MSI-H, gastroesophageal adenocarcinoma ·       14:40 – 18:03 First-line treatment for ESCC ·       18:04 – 22:04 Second- and third-line therapy for gastroesophageal adenocarcinoma and ESCC ·       22:05 – 24:38 Importance of guideline ·       24:39 – 27:45 Outstanding questions and future research   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.   My name is Brittany Harvey, and today I am interviewing Dr. Lakshmi Rajdev from the Icahn School of Medicine at Mount Sinai and Dr. Manish Shah from Weill Cornell Medicine, co-chairs on "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update." Thank you for being here today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you for having us. It is wonderful. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Rajdev and Dr. Shah, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into what we are here today to talk about, Dr. Shah, I would like to start first with what prompted the update to this guideline, which was previously published in 2023, and what is the scope of this updated guideline? Dr. Manish Shah: Yes, terrific. So even in the last few years, the pace of drug development in gastroesophageal cancers has just been astounding. So, what prompted this guideline is actually the practice-changing results for a new biomarker, CLDN18.2 hat was based on the GLOW and SPOTLIGHT studies, as well as a practice-changing study in HER2-positive disease where we added pembrolizumab to trastuzumab and chemotherapy for tumors that are HER2-positive and PD-L1 CPS 1 or greater. And then there were also new studies and new approvals in esophageal squamous cell cancer that you will hear about as well. So there were several studies, overall more than 5,000 patients were reported on, and that led to several new therapies, new indications, and it really necessitated this guideline. Brittany Harvey: Excellent. It is great to hear about all of these exciting updates in this space. So then to next review the key recommendations of this guideline by clinical question that the expert panel addressed. So, Dr. Rajdev, what is the recommended first-line treatment for patients with proficient mismatch repair, microsatellite stable, HER2-negative gastroesophageal adenocarcinoma? Dr. Lakshmi Rajdev: Thank you for that question. So historically, we have sort of used fluoropyrimidine and platinum doublets, which yielded a survival of about one year. More recently, immunotherapy and targeted therapy options have improved outcomes in patients with advanced esophageal and gastric adenocarcinoma, as well as squamous cell carcinoma. Patients with gastric and GE junction adenocarcinoma have a high rate of actionable alterations, so it is imperative that physicians test the following biomarkers upfront so that it can help guide therapy. The markers recommended by the ASCO panel are HER2, MMR or MSI, CLDN18.2, and PD-L1. And also, it was recommended to use NGS if feasible in this patient population. HER2, as we know, is expressed in about 15% to 25% of patients; PD-L1 expression occurs in about 80% of patients; MSI-high, deficient MMR is present in about 5% to 8% of patients; and CLDN18.2 expression is present in about 40% of patients. There is, of course, biomarker overlap. About 13% to 22% of CLDN18.2 patients are also PD-L1 positive. For patients with pMMR or microsatellite stable HER2-negative disease with PD-L1 expression greater than 1 and absence of CLDN18.2, the panel recommended a first-line therapy with fluoropyrimidine and platinum-based therapy in combination with immunotherapy. These recommendations stem from large phase 3 trials, and the agents approved in the United States are pembrolizumab, nivolumab, and tislelizumab. It has been shown that immunotherapy benefit is greater in patients with higher PD-L1 expression, and it is not possible to comment on the individual PD-L1 cutoff scores and sort of identify the optimal PD-L1 cutoff score that sort of balances benefits and harms. But what is recommended is that immunotherapy-based treatments can be offered in patients with a CPS score of greater than 1. With regard to the choice of immunotherapy agents, that is pembrolizumab, nivolumab, or tislelizumab, these agents are considered to have similar efficacy, and the selection of an agent could be based on dosing schedule, cost considerations, toxicity, and the method of administration. Typically, clinicians should avoid withholding the start of chemotherapy while awaiting biomarker testing, depending on the clinical scenario. Now, for patients with pMMR microsatellite stable disease that is HER2-negative with PD-L1 expression less than 1 and positive CLDN18.2 expression, zolbetuximab-based treatments or in combination with chemotherapy is recommended, and this is based on two global phase III randomized controlled trials, the GLOW and the SPOTLIGHT. And across both studies, the hazard ratio for the overall survival was 0.78, and similarly, there was also an improvement in progression-free survival favoring the zolbetuximab group compared to the chemotherapy group alone. An important note is that nausea, vomiting is commonly associated with zolbetuximab-based treatments, and the panel recommended prophylactic antiemetics, adjusting zolbetuximab infusion rates, pausing infusion temporarily, using non-prophylactic antiemetics, and hydration intravenously prior to discontinuation of zolbetuximab-based chemotherapy. So effective handling of the GI-related symptoms with zolbetuximab is recommended prior to discontinuation of therapy. Now, for patients with pMMR microsatellite stable HER2-negative gastric, GE junction adenocarcinoma with PD-L1 expression greater than 1 and CLDN18.2 positivity, the ones with the dual expression with CLDN18.2 as well as PD-L1 chemotherapy, the choice of therapy can be based on the degree of PD-L1 expression, the toxicity profile, the burden of symptoms, and the anticipated improvement in symptoms associated with response to treatment, the patient comorbidities, the prior medical and treatment history. So this decision needs to be made on a case-by-case basis, and these are some of the factors that we suggested that could potentially influence the choice of therapy. For patients with pMMR microsatellite stable disease that is HER2-negative and a PD-L1 expression less than 1 and an absence of CLDN18.2 expression, first-line therapy with fluoropyrimidine and platinum-based chemotherapy is recommended. So you can see we have segmented out patients based on PD-L1 expression, pMMR and microsatellite stable disease expression, and also based on CLDN expression. Brittany Harvey: Absolutely. And that first point you noted, I think is really important, that biomarker testing is really critical for treatment decision-making in this space. So then the next subgroup of patients that the panel looked at, Dr. Shah, what first-line therapy is recommended for patients with proficient mismatch repair, microsatellite stable, HER2-positive gastroesophageal adenocarcinoma? Dr. Manish Shah: So this was an update from a few years ago. So we have known for 15 years now that if you are HER2-positive, you should get trastuzumab plus chemotherapy. That was based on the ToGA trial. And the update now is based on a trial called KEYNOTE-811, where it examined the addition of pembrolizumab to trastuzumab and chemotherapy versus trastuzumab and chemotherapy, and there was a progression-free and overall survival benefit. And again, here, the biomarkers are important. If your CPS PD-L1 is less than 1, we would not recommend Pembrolizumab in that setting, so you would still get trastuzumab and chemotherapy. But if it is 1 or greater, the PD-L1 CPS score, then we do recommend pembrolizumab unless there is a contraindication to immunotherapy. The take-home message really is from the onset of diagnosis, please check your biomarkers. And I will just, it is worth repeating, it is important to check your PD-L1 status, HER2 status, mismatch repair status, and CLDN18.2 status. And then the optimal therapy, and it is outlined in the publication, is really biomarker-driven. We know that if we are able to hit the target that is overexpressed, we are going to have a better outcome. And Dr. Rajdev did mention where there is overlap, there can be a lack of data, and that is where we are with both PD-L1 positive and CLDN positive. Here we do have data in HER2-positive cases where if you are both HER2-positive and PD-L1 positive, you would combine trastuzumab and pembrolizumab for the best outcomes. Brittany Harvey: Understood. I really appreciate you detailing what is most important for each individual biomarker combination that patients may have. So then following that, Dr. Rajdev, what does the expert panel recommend for first-line treatment for patients with esophageal squamous cell carcinoma that is not amenable to definitive chemoradiation? Dr. Lakshmi Rajdev: There are three phase III randomized clinical trials that have influenced practice in patients with esophageal squamous cell carcinoma examining the benefit of immunotherapy in this patient population. The RATIONALE-306 was a randomized trial of tislelizumab plus chemotherapy with platinum and fluoropyrimidine or paclitaxel versus placebo with chemotherapy. And then you have the KEYNOTE-590, which compared pembrolizumab plus chemotherapy versus chemotherapy alone. And then you have CheckMate-648, which included comparisons of nivolumab plus chemotherapy versus nivolumab plus ipilimumab or chemotherapy. And the primary endpoints for these studies were overall survival, and they did look at subgroups with PD-L1 expression. They used TPS score greater than 1% in CheckMate-648 and PD-L1 CPS greater than 10 in KEYNOTE-590. The bottom line is that the overall hazard ratio for overall survival across this patient population was 0.72. So clearly, there is benefit in patients that express PD-L1 CPS greater than 1 for benefit for the addition of immunotherapy. Now, the benefit again in patients with a PD-L1 expression less than 1 remains limited, and so the panel has made a recommendation for using immunotherapy in combination with platinum-based chemotherapy in patients with a PD-L1 greater than 1. Again, we know that it is hard to make recommendations on what PD-L1 cutoffs are recommended in this patient population, meaning that should it be limited to patients with a PD-L1 of 1 to 4 or greater than 10? I think that the general consensus that has been gleaned from the data is that the higher the PD-L1 expression, the greater the benefit. I do want to comment on another option that is available in patients with squamous cell carcinoma compared to adenocarcinoma, and that is the combination of nivolumab and ipilimumab. Now, in CheckMate-648, nivolumab with ipilimumab was also recommended as a treatment option in patients that have a PD-L1 score of greater than 1. There was a survival benefit demonstrated with this combination compared to chemotherapy alone. And an important observation in this study is that, although there was a slightly increased rate in early death, but there was really no significant difference in PFS and OS compared to chemotherapy alone. Importantly, the treatment appeared to be pretty well tolerated by the study population. There was a notable difference in the objective response rate, which was 35% in the nivolumab plus ipilimumab group compared to patients receiving nivolumab and chemotherapy, where it was 53%. So superiority is, so the importance of chemotherapy in patients with esophageal squamous cell carcinoma is to be noted. However, there is no difference in overall survival and progression-free survival when using the combination of nivolumab and ipilimumab, and thus it affords a chemotherapy-free option for this patient population with esophageal squamous cell carcinoma and a CPS with a score of greater than 1. Brittany Harvey: Understood. I appreciate you reviewing the evidence underpinning those recommendations as well. So then the next patient population that the guideline panel addressed, what first-line therapy is recommended for patients with deficient mismatch repair, microsatellite instability-high, gastroesophageal adenocarcinoma or esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: The rate of MSI-high expression is about 3% to 7% across different studies. Now, the KEYNOTE-158 was a tumor-agnostic study in patients with non-colorectal cancers, and again, the problem with the MSI-high population, given that it is so rare, the numbers in the individual studies are fairly small. But consistent outcomes do emerge, indicating high response to immunotherapy. So in KEYNOTE-158, a response rate of about 46% was noted. The number of patients was small, it was about 24. In CheckMate-649, which is a study of chemotherapy plus or minus nivolumab in patients with advanced gastric adenocarcinoma, there was again a very small number of patients, and patients that were MSI-high or deficient MMR did experience substantial benefits with the addition of immunotherapy, with hazard ratios in the order of about 0.38. In KEYNOTE-062, again, it was a very small number of patients, again about 6% or so, and similar to CheckMate-649, a substantial benefit was noted in combination with chemotherapy, but also there were benefits noted with pembrolizumab alone. The RATIONALE-305 again was a study of tislelizumab in combination with chemotherapy and similarly showed benefits to the combination of chemotherapy plus immunotherapy in this patient population. I think that we are all aware of the dramatic benefits of immunotherapy in this particular subset of patients, deficient MMR MSI-high, and also we have seen in CheckMate-649 they did have a subset of patients that received nivolumab and ipilimumab. And in this patient population, they noted unstratified hazard ratio of 0.28. So I think that the overall consensus is that immunotherapy is a very important treatment modality in patients with deficient MMR MSI-high disease, given that a lot of the trials in gastroesophageal adenocarcinoma have utilized chemotherapy-based options, that is certainly a recommendation of the panel to use chemotherapy in combination with immunotherapy. However, on a case-by-case basis, the panel recommended immunotherapy alone as well, and given the high response rates noted in trials across different diseases as well as noted in this disease as well. Brittany Harvey: Certainly. And I appreciate you both for reviewing these first-line recommendations. So moving to later lines of therapy, Dr. Rajdev, what recommendations did the expert panel make for second or third-line therapy for gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: So, I think that the RAINBOW trial that investigated the utility of the addition of ramucirumab as second-line therapy has been around since 2014, and those results have led to the addition of ramucirumab to taxane-based therapy in the second-line setting. Based on the utilization of oxaliplatin and platinum-based therapy in the front-line setting, there may be patients that have an underlying neuropathy, and so we wanted to really include treatment options for this patient population so that an agent that is less neurotoxic could also be recommended in combination with ramucirumab. The RAMIRIS trial is one such trial where ramucirumab was combined with FOLFIRI, and it demonstrated benefit in combination with ramucirumab. So we have listed that as a potential treatment option for patients in the second-line setting who may have an underlying neuropathy or even for whatever reason that based on the toxicity profile, that needs to be the preferred option by a physician, that recommendation is new from the older guidelines that we have. With regard to the utility of PD-1 inhibitors, there really has been no benefit noted in the second-line setting with regard to overall survival or progression-free survival, so no recommendation is made for that option. I think an important study that has been recently presented is the DESTINY-Gastric04 trial, which really has been practice-changing and has led to the recommendation for trastuzumab deruxtecan in patients that have HER2-positive metastatic gastric or GE junction adenocarcinoma. Now, this is a phase III trial in patients who retained HER2-positive disease after progressing on front-line trastuzumab-based treatments, and the comparator for this trial was trastuzumab deruxtecan versus ramucirumab plus paclitaxel. There was significant improvement and progression-free survival in patients that received trastuzumab deruxtecan. The patients that were excluded from the trial are patients that have pulmonary problems, interstitial lung disease; that is one of the toxicities of this particular agent, and close monitoring and prompt initiation of therapy such as glucocorticoid treatment in patients who develop this toxicity was also highlighted by the panel. So to summarize, the new guidelines highlight the possibility of FOLFIRI plus ramucirumab as a second-line option and then trastuzumab deruxtecan as a later-line option in patients that still retain HER2 expression. And that is very important because the trial did retest patients whether they expressed HER2. As we know, in a substantial number of patients, there is downregulation of HER2, and there is emerging data that the benefit for subsequent HER2-directed therapies is best noted in patients that still retain HER2 expression. Brittany Harvey: Great. So as our listeners have heard, there are many recommendations and new treatment options for advanced gastroesophageal cancer. Dr. Shah, earlier you highlighted the importance of biomarker testing, but I would like to hear in your view, what is the importance of this guideline and how will it impact both clinicians and patients with gastroesophageal carcinoma? Dr. Manish Shah: So as we have discussed throughout this podcast, the treatment for gastroesophageal cancer, both adenocarcinoma and squamous cell cancer, is increasingly complex, increasingly biomarker-driven. And I think the value of the guideline is to place all of that into context. So it provides the data for why certain biomarkers are important, what therapies should be indicated. Not only that, but if you are able to review the guideline, it provides the details of each of these studies and summarizes them in a meta-analysis fashion to sort of give you the context, because sometimes the individual studies can be maybe a little bit discordant or confusing and the guideline attempts to harmonize all that. And then also, I think the tables are very, very interesting because they give you actual numbers in terms of how many patients over a thousand would this benefit or how many patients over a thousand would this cause harm in terms of nausea, vomiting, or other things like that. So it gives you context for helping clinicians and patients weigh the potential benefits of the novel treatment strategies against the potential adverse events. And then finally, the guideline does also provide an algorithm that you are able to follow based on the biomarkers, and those are in figures 4 and 5. So I think overall, it is a very comprehensive guideline. It intends to make more manageable a very complex subject, and you know, I really encourage our listeners to review it after listening to the podcast. Dr. Lakshmi Rajdev: If I can add to that, I think that what is also really good about the guidelines is there are quick summaries. So if someone is busy in the clinic, of course, there is the opportunity to review the data supporting the guidelines in great depth in the manuscript, but what is also really good is that there are good summaries. In the event that you are very busy, you can easily identify what the recommendations should be for that particular patient based on these summaries. Brittany Harvey: Absolutely. Listeners are encouraged to review the full guideline, including those tables and figures that may be more helpful when they are looking for something quick to look at in the clinic as well. So, as you both mentioned, there have been a number of recent practice-changing trials in this area. So I imagine there is still a lot of ongoing research as well. So Dr. Shah, what are the outstanding questions regarding treatment options for patients with locally advanced unresectable, advanced, or metastatic gastroesophageal carcinoma? Dr. Manish Shah: I think we touched upon it a little bit. The guidelines are based on the data available, and they are primarily examining one novel therapy with chemotherapy in a specific biomarker population. But as you know, the biomarkers are not either/or; you are not either CLDN18.2 positive or PD-L1 positive. A portion of patients could have dual biomarkers, and you know, I think that we are generating data on how to manage those patients. At the recent GI Symposium in January this year, the ILUSTRO trial was presented by Dr. Shitara, which looked at combining zolbetuximab and chemotherapy with immunotherapy for dual-positive biomarkers, and that is leading to a phase III study that has begun to enroll. So unanswered questions are: how do we manage dual-positive biomarkers? The other thing that was mentioned is that the current data for mismatch repair deficiency involve chemotherapy plus immunotherapy. Only squamous cell cancer is there a study with a positive non-chemotherapy kind of backbone, that is CheckMate-648 that Dr. Rajdev mentioned. As we move forward, it will be good to get data on non-chemotherapy options in certain biomarker-positive populations. And then finally, another update, which is likely to be practice-changing, is the HERIZON-GEA-01 study that looked at zanidatamab, which is another biparatopic antibody that targets HER2, and that is likely to change practice. And as that data gets published, we may look to even do a rapid update for the current immunotherapy and targeted therapy guideline that is just being published. Dr. Lakshmi Rajdev: So, if I can add to that, there are numerous ADCs that look very interesting. There are bispecific antibodies; in fact, the zanidatamab is a bispecific antibody showing improved activity in patients with HER2-positive disease. So I think there are studies from Asia looking at CLDN CAR T-based therapies. So, I think that there are a lot of novel agents and a lot of excitement in the field. We know that the bemarituzumab study, unfortunately, the FGFR2 inhibitor failed to demonstrate any benefit, but I think that there are other agents that are being explored, so there are newer targets, newer agents, ADCs, bispecifics that could potentially change the field in the future. Brittany Harvey: Yes, we will look forward to the data to address these unanswered questions and new agents and inform future guideline updates. So, I would like to thank you both for all of your work to review the evidence here and update this important guideline, and for your time today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/gastrointestinal-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Vorresti ricevere notizie, saluti, auguri dalle Apostole della Vita Interiore?Lasciaci i tuoi contatti cliccando il link qui sotto e con la nostra nuova rubrica digitale potremo raggiungerti.https://www.it.apostlesofil.com/database/- Premi il tasto PLAY per ascoltare la catechesi del giorno e condividi con altri se vuoi -+ Dal Vangelo secondo Matteo +In quel tempo, Gesù disse ai suoi discepoli:«Se la vostra giustizia non supererà quella degli scribi e dei farisei, non entrerete nel regno dei cieli.Avete inteso che fu detto agli antichi: "Non ucciderai"; chi avrà ucciso dovrà essere sottoposto al giudizio. Ma io vi dico: chiunque si adira con il proprio fratello dovrà essere sottoposto al giudizio. Chi poi dice al fratello: "Stupido", dovrà essere sottoposto al sinèdrio; e chi gli dice: "Pazzo", sarà destinato al fuoco della Geènna.Se dunque tu presenti la tua offerta all'altare e lì ti ricordi che tuo fratello ha qualche cosa contro di te, lascia lì il tuo dono davanti all'altare, va' prima a riconciliarti con il tuo fratello e poi torna a offrire il tuo dono.Mettiti presto d'accordo con il tuo avversario mentre sei in cammino con lui, perché l'avversario non ti consegni al giudice e il giudice alla guardia, e tu venga gettato in prigione. In verità io ti dico: non uscirai di là finché non avrai pagato fino all'ultimo spicciolo!».Parola del Signore.

Bütün bir hayatını tek bir amaçla yaşayan biri daha: Gelmiş geçmiş en büyük mimarlardan Antoni Gaudi.Bu bölümde Gaudi'nin hayat hikayesini dinleyeceksiniz.Mimarlık diplomasını alırken hocasının dediği gibi: "Ya bir deli ya da bir dahinin" elinden çıkabilirdi onun yaptığı binalar, parklar, kiliseler.Rengarenk, uçuk, hiçbiri birbirine benzemeyen ama hepsi Gaudi'nin elinden çıktığını adeta bağıran eserler koydu 76 yıllık ömründe.Başlamasından bir yıl sonra devraldığı Sagrada Familia ise hala inşaat halinde.Geçenlerde en büyük kulesine eklenen başlıkla en yüksek noktasına ulaştı bu şaheser: 172,5 metre.Gaudi'nin ilginç yaşam öyküsüne hoş geldiniz.İyi dinlemeler.Biliyorsunuz Yeni Haller sizlerin desteğiyle yayın hayatına devam eden bir podcast kanalı.Beni aşağıdaki link'lerden destekleyebilirsiniz:www.patreon.com/yenihallerYeni Haller'in bir de Buy Me A Coffee hesabı var artık. Buradan destek olmak çoook daha kolay. Patreon'da sorun yaşayanlar için açtım efendim. Buyurun:https://www.buymeacoffee.com/yenihallerBir de bu sezon spor basınımızda apayrı yeri olan, ben ustam olarak kabul ettiğim Yiğiter Uluğ'la T24'ün Youtube kanalında bir spor programına başladık. Korkmayın, sadece futbol konuşmuyoruz. Hele sahadaki skorları, maçları hiç konuşmuyoruz. Yeni Haller tadında spor sohbeti isteyenler için:Yiğiter Uluğ ve Eray Özer'le GazozunaBana ulaşmak için:https://www.instagram.com/eray_ozerhttps://twitter.com/ErayOzeryenihallerpodcast@gmail.com  

Avustralya'da trafik kazalarında ölenlerin sayısı artıyor ve yeni uyarılar, ülkenin 2030 yılına kadar ölümleri yarıya indirme hedefinden uzaklaştığını gösteriyor. Geçen yıl Avustralya yollarında bin üç yüzden fazla insan hayatını kaybetti ve 2026 başlarındaki rakamlar iyileşme belirtisi göstermiyor. Sektör liderleri ve mağdur hakları savunucuları, ve ayrıca aileler her gün trafik kazalarının sonuçlarıyla yaşamaya devam ederken, daha güvenli yol tasarımından sürücü davranışlarında değişikliklere kadar acil eylem çağrısında bulunuyor.

EXECUTIVE SUMMARYIn 2026's 'forever layoff' era, women leaders who master continuous improvement leadership outperform peers, reduce their layoff risk, and accelerate promotions. Olaf Boettger's 27-year Kaizen framework — courage, humility, discipline — turns daily small improvements into extraordinary career results.Key stat: Toyota workers are 2x more productive than competitors using this same system.? QUICK TAKEAWAYS•       Continuous improvement leadership doubles your career productivity vs. peers who stop learning•       The 3 capabilities every woman leader needs: courage to name problems, humility to keep learning, discipline to stay consistent•       Kaizen's daily 15-minute team meeting is directly applicable to your own career self-management•       GE's turnaround under Larry Culp proves CI works in any industry — finance, tech, healthcare, or your own career•       In 2026's 'forever layoff' climate, CI skills signal indispensable strategic value to any organizationIf you're a woman leader in 2026, the job market has changed dramatically — and not in your favor. Glassdoor's Worklife Trends report calls it the 'forever layoff': small, rolling cuts that never make headlines but keep talented executives in a constant state of anxiety. Meanwhile, AI is reshaping roles at every level, and the competition for standout positions has never been fiercer.As an executive coach with over 30 years of experience (MA, MFT, PCC) and host of the Women's Leadership Success Podcast — ranked in the top 1.5% globally with over 750,000 downloads — I've interviewed more than 144 of the world's top leadership experts. When I heard Olaf Boettger's approach to continuous improvement leadership, I immediately knew this was the missing framework most women leaders had never considered.Olaf spent 27 years at Procter & Gamble and Danaher — two of the most operationally excellent companies on earth — mastering the Japanese Kaizen philosophy. What he discovered translates directly to career acceleration: the same system that doubled Toyota's worker productivity and powered GE's biggest turnaround in American history can supercharge your leadership brand and make you the candidate no one can afford to pass over. The 2026 Career Reality: Why 'Working Hard' Is No Longer Enough The data is sobering for women leaders right now. According to Glassdoor's 2025 Workplace Trends report, small layoffs — under 50 people — now represent 51% of all job cuts, up from just 38% in 2015. These 'forever layoffs' create cultures of anxiety where talented women question their value daily.At the same time, female manager engagement dropped seven percentage points in 2025 alone — the steepest decline of any group, according to Gallup research. Women leaders are being asked to do more with less, carrying teams through AI disruption and RTO mandates, while their own career advancement stalls.The traditional answer — work harder, be more visible, volunteer for every high-profile project — simply isn't scaling. In a market where 45% of employers rate the job outlook as 'fair' at best, you need a completely different strategy. You need continuous improvement leadership. ? Ready to transform your career trajectory?  Download our FREE Leadership Branding Blueprint Accelerator and discover:•       A proven system to document your impact and accelerate promotions•       How to build a leadership brand that makes you the obvious choice•       A measurable framework for expanding your organizational influence•       Strategic positioning for high-visibility, career-defining initiatives•       The same approach Sabrina uses with Fortune 500 executives to 3x their promotion speed? GET YOUR FREE LEADERSHIP BRANDING BLUEPRINT ACCELERATOR What Is Continuous Improvement Leadership? The Kaizen Framework Explained Continuous improvement — known in Japanese as Kaizen, meaning 'change for the better' — originated at Toyota nearly 90 years ago. After World War II, with limited resources and a need to compete globally, Toyota developed a system to extract maximum quality and efficiency from every process. That system, now called the Toyota Production System, became the foundation of what we know as Lean, Six Sigma, and the Danaher Business System.For women leaders, continuous improvement leadership means applying these same principles to your career, your team, and your organization. It is not a one-time initiative or a January resolution. It is a daily practice — a permanent operating system.The Three Foundation PrinciplesOlaf distills continuous improvement leadership into three core principles:Kaizen — The belief that there is always a better way. This is not about being self-critical; it is about being growth-oriented. Every interaction, presentation, and leadership decision is an opportunity to iterate and improve.Go to Gemba — Go to the real place. Stop relying on slide decks and secondhand reports. As a leader, this means visiting your stakeholders, understanding what your team actually experiences day-to-day, and staying close to the work that creates value.Customer focus — Always anchor to what your 'customer' values. In a career context, your customers are your executive stakeholders, your team, and the business outcomes you're hired to deliver. Everything you do should be filtered through: does this add value for them?The Three Capabilities That Determine SuccessAccording to Olaf, your mindset determines everything. Leaders who succeed with continuous improvement possess three non-negotiable capabilities:CapabilityWhat It Looks Like in PracticeWhy Women Leaders Need It NowCOURAGEHonestly naming when your performance or your team's is 'red' — even when the culture rewards positivity over truth.In 2026's performance-pressured environment, leaders who surface problems first are seen as strategic — not weak.HUMILITYStaying open to learning regardless of your experience level. As Olaf says: the best leaders he's known, including P&G's CEO A.G. Lafley, were the most humble.Imposter syndrome tempts women to prove they already know everything. Humility is the counterintuitive superpower.DISCIPLINEShowing up for improvement consistently — not just in January. Committing to the decade, not the quarter.Career advancement compounds. The women who stand out in 2026 are those who have been quietly improving for years. The Business Case: What Continuous Improvement Leadership Actually Delivers For skeptics — and Olaf acknowledges that many leaders initially resist this approach — the numbers make a compelling argument. Toyota, the originator of this system, generates roughly twice the revenue per employee compared to its nearest competitors. Danaher, where Olaf spent the bulk of his career, has sustained approximately 15–16% compound annual growth for 40 consecutive years.The most visible example is GE's transformation under Larry Culp — the former Danaher CEO who took over when GE was in deep financial trouble. Using continuous improvement as the operating backbone, Culp and his teams executed what many consider one of the greatest corporate turnarounds in American business history, eventually splitting GE into three highly successful independent companies.On a practical level, Olaf shared a specific case study from a Danaher acquisition: a company delivering orders on time just 50% of the time. Using CI methodologies, that number rose to 95%. For context, if Amazon delivered your packages on time half the time, you'd stop using Amazon. A 45-percentage-point improvement is not incremental — it's transformational. TRY THIS NOW (10 Minutes)Apply Olaf's Red/Green method to your career right now: Identify one goal you have for your career this quarter (promotion, salary increase, high-visibility project).Set a specific target. Write your current actual. Color code it: are you green (on track) or red (below target)? If red — write one sentence explaining why.Then write one action you will take this week to close the gap. That's continuous improvement leadership in action. Do this every Monday.  How to Apply Continuous Improvement Leadership to Your Career in 2026 The beauty of Kaizen is that it scales from a Toyota factory floor to your personal career strategy. Here's how to translate Olaf's framework into your daily leadership practice:The 15-Minute Daily Leadership HuddleAt every Danaher facility, teams hold a 15-minute standing meeting every morning. They review five metrics — safety, quality, delivery, inventory, productivity — and ask: are we red or green? If red, why? Who does what by when?For your career, your five metrics might be: stakeholder relationships, project delivery, skill development, visibility, and team performance. A daily or weekly 10-minute self-check asking those same questions creates the discipline of continuous improvement at the individual level.Visual Management for Your CareerOlaf emphasizes making performance visible. In organizations, this means color-coded boards. For your career, this translates to maintaining a simple achievement tracker — a running document of your wins, metrics, and impact — that you review weekly. This directly feeds your Leadership Branding Blueprint and becomes the evidence base for promotion conversations.The Growth Mindset + Kaizen ConnectionOlaf's PhD research connected him deeply to Carol Dweck's work on fixed vs. growth mindsets. Dweck's research demonstrates that individuals who believe abilities can be developed through dedication consistently outperform those who believe talent is fixed. Continuous improvement is the operational expression of growth mindset — it gives you the system that turns that belief into measurable career results. Your 7-Step Continuous Improvement Career Action Plan Step 1 (10 min): Define your career target.

Creating Engaged Employees and Loyal Customers   Shep interviews Stephen Baer, Co-Founder and Managing Partner of Engagency. He talks about his new book,  Stickology, and how building strong emotional connections and engaging both employees and customers leads to lasting loyalty.  This episode of Amazing Business Radio with Shep Hyken answers the following questions and more:    How does internal employee engagement influence external customer experience?  Why is it important for organizations to go beyond surface-level personalization in delivering customer experiences?  How can companies strike the right balance between friendly service and convenience to create lasting loyalty?  How can organizations move from transactional interactions to building relationships with their customers?  Why is it essential to invest in employee experience to drive customer satisfaction?  Top Takeaways:    Internal engagement is the foundation of strong customer loyalty. What happens inside your organization is always felt by your customers on the outside. If your employees are engaged, respected, and motivated, customers feel that in every interaction with your brand.   When organizations invest in their people, the result is better service and stronger customer relationships because empowered employees have the confidence to go above and beyond for customers.   Engagement isn't just good for workplace culture. It's good for business. Companies that focus on both employee and customer engagement see more revenue, higher employee and customer retention, and outpace their competitors.   It's easy to form a connection, but lasting loyalty requires deeper engagement. Connections made quickly can fall apart just as fast if the next interactions are inconsistent. Genuine engagement takes time and is operationalized so it ingrained in the culture and felt in every interaction.  Personalization by itself, even when powered by advanced technology, is not enough to build lasting loyalty. Relying on algorithms alone will expose a brand to being outgrown by its customers or out-innovated by its competitors. Customers stick with brands that make them feel emotionally connected and valued. Human elements, not just algorithms, are what creates long-term fans.   Convenience is no longer a unique advantage. It is an expectation. Today's customers want easy, seamless interactions everywhere they shop. To stand out, businesses need to pair convenience with authentic, memorable service.   Customers are going to talk about their experience with a company. When employees are engaged, they create advocates, customers who often spend more, and are more likely to recommend the business to others.   Plus, Stephen shares more insights from his book, Stickology: How to Build Unbreakable Connections with Employees and Customers for Life. Tune in!  Quote:   "It's not just about connecting. It's about building a relationship. It's about making that person feel seen, heard, valued, and empowered, whether they are a customer or an employee. It takes time, but the bond holds together stronger."  About:    Stephen Baer is the author of Stickology: How to Build Unbreakable Connections with Employees and Customers for Life, and the Co-Founder and Managing Partner of Engagency.  He has 30 years of experience in behavioral science and engagement from leadership roles at companies such as The Game Agency, Atari, and GE.  Shep Hyken is a customer service and experience expert, New York Times bestselling author, award-winning keynote speaker, and host of Amazing Business Radio.   Learn more about your ad choices. Visit megaphone.fm/adchoices

El director de Más de uno ha destacado en su monólogo el 155 que le ha aplicado la dirección de Génova a María Guardióla para asegurase un pacto con Vox en Extremadura.

Dean reviews the best items he found at this year's International Builders Show. Starting with game changing appliances like GE's new high-capacity washer drier combos by GE that are not only faster but more efficient for your clothes, are these realistic for the every day homeowner? Dean details the pros and cons of these units. Also covered new construction products and information geared toward being fire-resistant to help homeowners keep their homes safe in high fire areas and various products that make life easier for homeowners. See omnystudio.com/listener for privacy information.

Dean reviews the best items he found at this year's International Builders Show. Starting with game changing appliances like GE's new high-capacity washer drier combos by GE that are not only faster but more efficient for your clothes, are these realistic for the every day homeowner? Dean details the pros and cons of these units. Also covered new construction products and information geared toward being fire-resistant to help homeowners keep their homes safe in high fire areas and various products that make life easier for homeowners. See omnystudio.com/listener for privacy information.

Dean reviews the best items he found at this year's International Builders Show. Starting with game changing appliances like GE's new high-capacity washer drier combos by GE that are not only faster but more efficient for your clothes, are these realistic for the every day homeowner? Dean details the pros and cons of these units. Also covered new construction products and information geared toward being fire-resistant to help homeowners keep their homes safe in high fire areas and various products that make life easier for homeowners. See omnystudio.com/listener for privacy information.

The Smarter Way To Pick Winning Stocks  Podcast: Find out more about Blueberry Markets – Click Here Find out more about my Online Video Forex Course Book a Call with Andrew or one of his team now Click Here to Attend my Free Masterclass Checkout the Tykr Platform here. #624: The Smarter Way To Pick Winning Stocks In this video: 00:14 – Sean Tepper – found of TYKR 04:55 – How does this software help? 08:50 – TFTC also helps create successful traders 12:25 – Is social media helpful? 16:20 – Multiple brokers or one? 22:18 – TFTC creating a trading bot program 28:16 – 60,000 stocks analyzed 32:45 – Contact Sean Andrew Mitchem Hello, everybody. It’s Andrew Mitchem here at The Forex Trading Coach. And today I’m really pleased to be joined by Sean Tepper, who’s the founder and the CEO of Tykr. Welcome along. Sean. Sean Tepper Andrew. Good to be here. Andrew Mitchem Awesome to have you. Sean, could you introduce yourselves to everybody and let us know who you are and what you do and what we’re going to talk about? Sean Tepper – found of TYKR Sean Tepper Sure. Yeah. My name is Sean Tepper. I’m the founder of TYKR, as Andrew said. And long story short, TYKRs a platform that helps people buy and sell stocks with confidence prior to that. My background is about 20 years in tech, 15 years investing, and I kind of created TYKR as a solution to a frustration in the markets. Sean Tepper And we could dive into what that frustration is, if you’d like. Yeah. But yeah, I had to create a solution because it was very hard to make decisions when I first got started. And that’s where really TYKR came from. And, but yeah, fast forward to today. We’ve got a little over, 13,000 customers in about 50 countries, including where you’re based. Sean Tepper New Zealand. Andrew Mitchem Oh that’s good. Yeah. So you had 50 countries. That’s a that’s an awesome effort. And, and Sean, I was reading about, you know, you started, on your website says, in, you know, 2011 to 2015, you were trying to figure out what wasn’t there to help you. What did you find back then? Was the biggest frustration that led to TYKR happening? Sean Tepper Yeah. So when I first got started, you know, I think I joined E-Trade. And, you know, there’s so many brokers these days, it’s hard to keep track of. But as soon as I joined, I had no idea what to do next. So I started going on YouTube researching where do you go to invest? Like looking up different investing platforms? Sean Tepper I found a few of our competitors, like Seeking Alpha and Motley Fool, and they do a fine job, but it’s still very difficult to truly know the difference between a strong stock and a weak stock is is very frustrating. And for context, my background is in tech, but to go, layer deeper, it’s actually in process engineering. Sean Tepper Like I’ve worked a lot for GE and Koehler. And the rule is in process engineering, if you have 100 data points, you cannot present that to a customer or an executive. You have to roll it up to ideally a binary decision like yes or no or a traffic light. And I was complaining at that time, like, am I the only one complaining about the fact that there’s no process engineering lens layered over investing like, this is insane. Sean Tepper Like nobody’s making it easy. And that was kind of the green light I was thinking of, like, hey, if I could figure something out here, I think the big solution is a create a process engineering solution in the world of finance and apparently I’m the only one really doing that today, other than the few platforms that say buy or sell. Sean Tepper But I don’t really recommend that. But yeah, that was that was the beginning. And it took about a year to build this Excel sheets. And I give you context here, I found a lot of inspiration from Phil Towne. He wrote a few books on value investing. Do you know Phil Towne? Andrew Mitchem No, I don’t know. No. Okay. Sean Tepper Your your audience may be interested. He wrote a book. One of them is rule one. The other one is payback time. I really provided some. Yeah, yeah. You know, rule one investing, Warren Buffett. We can talk about that. But, yeah, I, I found some of the calculus in his books, put it into Excel, and I ended up coming up with about 50 data points to analyze the stock. Sean Tepper And then on top of that, I created a traffic like rating system where stocks are either on sale, watch or overpriced. That’s green, gray or red. And I used it the next 4 or 5 years on my own, making returns between 15 and 50%, and my returns still fall in that range today. Our customers actually fall in that range as well. Sean Tepper But yeah, I, I wanted to make sure I’m using my own money testing it to make sure it works, not just like four weeks or four months. I went like that over four years. And then it was 2019 was the inflection point when I’m like, I think I’ve got a solution here, but let’s just confirm. Sent the sheet to a few of the retail investors and everybody’s like, I’m not going to use this Excel sheet. Sean Tepper This is insane. You got to create a software. So that right. That was the green light. Let’s go create a SaaS platform. And took a year to build the first version. And the first version was not pretty. But yeah, fast forward to today. That’s where we’re at. But yeah. Andrew Mitchem They Nimrod when you look back on them. Sean Tepper Yeah, right. It was like the, the metaphor I use is it felt like I was building a physical prototype made of like, and duct tape and cardboard. It was not pretty videos. It’s pretty ugly. But you get feedback from your customers and you just keep making it better, and it actually turns into something. How does this software help? Andrew Mitchem So, yeah, awesome. That’s brilliant. So fast forward then to today. Why would someone come and use what you have and I suppose in a practical basis, how does it help them? What are they. What do they input? What do they use to make decisions for them? Sean Tepper Sure. Yeah. So I’ll give you some of the the subjective reasons and then we’ll get into the objective and why that’s actually important to our, our broker partners. But our rating system again process engineering, it doesn’t sound very glamorous, but the concept of making decisions very easy for people, it is very true in most industries. So we we use the process engineering lens. Sean Tepper Plus we take a lot of inspiration from Duolingo for language learning in our opinion. Like what? They’ve got over 600 million users. They’re doing something right. We’re teaching people how to learn a language with these micro learning modules. And I’m like, we need to do the same thing in our platform, but it’s got to be investing focused. So we’ve got these modules peppered around that quickly teaches people how to invest in you put the two together, the rating system, plus the simplified education that helps people. Sean Tepper And it’s not our guarantee, but it’s it’s something we let people know upfront that 90% of customers is actually over 90. But we say 90% of customers that use TYKR are able to go from a beginner to confident an investor in 14 days or less. It’s very quick. Wow. And what does that mean from an objective standpoint? And this is what matters most to brokers, which is most brokers we’re talking to have two big problems. Sean Tepper And number one, very little transaction volumes, like somebody will join on day one and they’ll wait three months or six months or nine months, and then make another trade. And the other issue is the average account size is less than 5000. While with TYKR after five years. Now we’re we track like a lot of data points to see our, investors behavior. Sean Tepper And typically people make 30% more transactions after joining TYKR. And their average account size is about $180,000. So what that tells us is and it tells. Right. So these people are their confidence is skyrocketing and they’re adding more money from their checking account or their savings. So it’s not sitting in a low interest vehicle. So so there you go. Sean Tepper That’s how we’re different. I’ll give you one more way where different in your audience may appreciate this is TYKRs. Calculations are actually open source for personal use. And the SEC really likes that. Like we had an audit done to make sure we fall in that publisher exclusion category. We could talk about that in a minute, but making sure we’re not we’re not giving financial advice, but this firm we’re talking to and we had another we’re actually had two firms. Sean Tepper Take a look. They were both very impressed that we we put those calculations out and I’m like, I’m, I’m actually not concerned anybody’s going to take it because it’s even though it’s relatively simple math, it’s a lot of it. And try to put together in a software what would take you a really long time. So fortunately nobody’s tried to duplicate it. Sean Tepper But the calculations are out there. Andrew Mitchem Yeah, well, for the sake, I was looking on your your purchase, page. Your pricing page. For the sake of $50 a month, you just use it. Wouldn’t you? Rather than trying to reinvent it or. Sean Tepper It exact right at the base price is like, you’re saying 15, 15 bucks a month or 99 a year? You’re right. It’s like, oh, okay. So here’s the here’s the calculations. Yeah. I’m not going to reiterate. That’s where it. Andrew Mitchem Is. I mean in in lifetime working it out will spend $100 a year same. Sean Tepper Same prices Netflix their. Andrew Mitchem Data. Exactly. Yeah a lot more educational. Yes. Sean Tepper Yes. TFTC also helps create successful traders Andrew Mitchem Thank you. So it it sounds like although we’re in, slightly different markets within the overall similar markets now, we have something very similar going on, which is amazing is we’ve never met obviously, before, you know, 20 minutes ago, and that we find that our clients would be very similar to yours. The average forex person’s out there, small account, scared to trade, or they do the opposite and they do silly things and they make us even money and then lose it all, which inevitably happens. Andrew Mitchem And then they blame the break on the market. And that’s where we find our clients are different as well. You know, they have confidence that low risk approach. They they know what they’re doing, what to look for, when to do it. And therefore when they go to a broker brokers out there because, you know, the client’s got a hugely, bigger account and trading more often. Andrew Mitchem So it’s incredible how education and lack of it can affect so many people in this. Seriously. Yeah. It’s crazy. Yeah. Now, Sean, you mentioned, about the no financial advice, you know, situation. And again, coming back, that’s where we’re similar, you know, what’s your take on the no financial advice? Sean Tepper Yeah. So with the SEC, there’s I don’t have the exact, it’s like rule 102-5 or whatever. I’m making that up. But yeah, they’re essentially three rules you have to follow with staying in the publisher exclusion category. And there are companies and there are guys out there, some women as well, that they they get into some some shaky ground or gray areas where they push the envelope and they can get into some some big legal trouble. Sean Tepper So the three rules really go as follows. Number one is all information has to be factual. Like we can’t say like, hey, because I like x, y, z CEO, I think the share price is going to $2,000 a share. That’s crazy. We have to present the data like everything we do is really based off the fundamentals. We don’t cook any books. Sean Tepper We don’t skew the financials. It’s like, hey, here’s the EPS, here’s the revenue, here’s the net income, here’s the debt. Bam, roll it up to our calculations. And there’s your score. Keep it very simple right. Number two is and this is actually pretty easy to follow is we can’t ask our customers their age their risk level when they want to retire and then give them recommendations based on that criteria. Sean Tepper That is described as personalized financial advice. So very easy. Like okay, so don’t ask those personal questions. And number three everything has to be regular. And what does regular mean. It means all information we we put out has to be like every day or every week, which it’s we update our data every day. We can’t do and this is a common problem with a lot of discord and WhatsApp groups. Sean Tepper And so I’ve been told from the SEC, which is pump and dumps, is like, hey, go buy as much of GameStop by Tuesday. And then the very next day, without telling anyone, they’ll go sell a bunch of GameStop or whatever stock they they can come up with. And that is actually a common issue because you can make a lot of money in short order. Sean Tepper So, yeah, no, no irregular posting. It has to be regular posting. So yeah, those are the three rules with the publisher exclusion. And to be honest with you, but actually pretty easy to follow. Is social media helpful? Andrew Mitchem Yeah, yeah. That’s good. Do you find you mentioned on social media type of apps? Do you find that those, causing problems generally for people because they just think they’re going to find something that’s going to solve all their life’s financial problems? Sean Tepper You mean like our customer is going on social media and reading comments. Andrew Mitchem To make sure customers, but just general people out there and in general isn’t there going to find some app and follow something and it’s suddenly going to give them all the magical answers? Sean Tepper No. In general, I think most people are skeptical, which I think is good. They’re not going to like, you know, like, for example, they’re not going to come to tinker right away and be like, oh, this is this is my savior. That’s that’s not the case. We want people to be skeptical. And we always tell people like, don’t like, I’ll talk about Tinker all day, but don’t even take my word for it. Sean Tepper I always say, go to Trustpilot, see what our customers have to say first before you even think about it. And then our model is, it’s a trial 14 day trial. And then we also have a 30 day money back guarantee. So even when your credit card is charged, if you want to refund, we’re not going to fight you on it. Sean Tepper It’s like it’s 15 bucks. That’s right, that’s right. It’s like we’re not going to split hairs on this, but it’s like you want to create a platform that it’s very easy to join is very easy to learn about. You can see what your customers are saying. It’s easy to test drive. Those are kind of the boxes I like to check when I join a platform because I’m using other software to build TYKR, whether it’s a marketing software or analytics or email marketing or whatever, right. Sean Tepper I want those things. So I’m like, I’m going to do the same thing with my own platform. But coming back to the skepticism, I think it’s good. It’s good to have a healthy amount, and it’s good for people to not only, like join TYKR, but go have like join our competitors, see what they have to say. And sometimes you’ll get things to line up like let’s say it’s a stock you really like and you’ve got, you know, TYKR, Motley Fool and Seeking Alpha are all like, hey, this is this is a strong stock, not a buy stock, but its financials are strong. Sean Tepper That creates layers of confidence is how we phrase it. Yeah. Creating those layers of confidence gives people more confidence to move forward. Andrew Mitchem Yeah yeah that’s good. And I noticed also on your on your offer there that you talk about cryptos as well Matt. Obviously it’s the, the big thing that people want to talk about and we’ll see more recently we’ve seen some big drops as well. Yeah. How, how do people finding using your software or on cryptos. Andrew Mitchem Because it’s, it’s like one of the markets that we kind of cross over on. Sean Tepper Yeah. So with crypto we weren’t originally going to add it to the platform, but a few people were like, hey, can you add crypto from a tracking perspective? Now for context, we have three assets in TYKR. We have stocks, ETFs and crypto ETFs. It’s easy to analyze because it’s really just a bundle of stocks. So we analyze each individual stock. Sean Tepper We roll them all up. If it’s let’s say 500 stocks within an ETF. You can create you can calculate what is the average score within come to that on sale watch over priced. But when it comes to crypto as you know there’s no income statement cash flow statement A balance sheet is not a business, it’s just a digital asset. Sean Tepper But again, we had customers that were like, hey, you got a lot of good tracking tools, like you can set alerts on my dates and prices and really anything you want within TYKR. And so they’re saying like, can you add crypto within so we can keep track of all of our favorite assets in one clean location. And my response to that was, oh yeah, no problem. Sean Tepper We’ll add crypto to this tool. But there’s not a lot of analysis you can do there because again, it’s not a business. Multiple brokers or one? Andrew Mitchem Yeah, yeah. Fair enough. And also I noticed that you said about the broker connection. So one of your pricing models, that’s one broker three and five. Correct. What would be the reasons around someone needing, say, three brokers or five brokers as opposed to one. Sean Tepper Yeah. So the reason is typically your employer is going to issue you A41 like here in the states, of course, we get A41KI don’t know, in New Zealand you call it a pension like they do in, Europe. Andrew Mitchem Yeah. Kiwisavers called but yeah it’s that has is our name. Yeah. Sean Tepper Okay. Exactly. So you’re going to have that is going to be one retirement vehicle. And that’s typically set up with like here in the States. The two big ones are typically fidelity and Empower. There’s also Schwab. But then you’re probably going to want to do some trading on your own. So then here in the States some of the popular choices are Robinhood. Sean Tepper You’ve got E-Trade, you know. So there’s your second one. And then sometimes you’re going to have like an inherited account from a family member, you know, that could be on a different account. And if you don’t roll it over to your current broker, well, guess what? You’ve got a third broker sitting in place. But I get this. I’ve talked to people that have they’ve had more than five different brokers on my response. Sean Tepper So that is why. Yeah. So. Right. It’s it’s it seems unorganized. But we created the three tiers the premium premium plus an advanced premium. You get one broker premium Plus you get three in advance. You get five. We usually like 99.9% of the time. We don’t see people with more than five brokers. But like for example, between my wife and I, we have like we have three. Sean Tepper So yeah. Andrew Mitchem Okay. So with this allows someone to make their analysis and then connect directly through to that broker via your software. Is that how it works. Sean Tepper Yeah. Yeah. So yeah when when you join your broker and we’re really good complement to a broker will never replace it. We don’t want to be a broker dealer. That’s a legal name for their business model because we don’t hold any assets. We don’t hold people’s money. We’re just analytics. So yeah, when people join, you can sync up with your broker. Sean Tepper And what that does is it automatically updates your portfolio in TYKR every day. And it’s a much cleaner interface than most brokers out there. I, I’m never going to talk down about brokers, but it’s like their job is to protect people’s money. But when it comes to analytics dashboards or giving, like education or analytics, it’s that’s not their specialty, nor will it really ever be. Sean Tepper So we fill that gap, we complement and we make it easy to see because some people are like, I don’t I don’t actually know how much money I have because the dashboards in my broker’s so hard to use them, like just sync up your account TYKR and it’s going to kind of summarize it for you. Yeah, yeah. Andrew Mitchem That’s interesting. That makes a lot of sense. Makes life easy for people. And also I see that you have a mobile app. So can someone get the exact same information on the app. But they can all the desktop. Sean Tepper It’s pretty much the same experience. We try to release our features, if not the same day within the next week or two. Like if we need to deploy something to web or web app, we try to do the same thing to the mobile, that allows people to write. They can kind of analyze stocks and the gold or standing in line somewhere at Starbucks, whatever. Sean Tepper The mobile app, I will say this has an additional feature, which is the Duolingo inspired learning modules that kind of like swipe right, swipe left type feel. We don’t have that in the web app today, but we’ve had a few people say, hey, can you also add that to web? Well, that’ll come soon. But yeah, it’s pretty much the same experience. Andrew Mitchem And what’s the AI investing helper that’s not like yeah, humming live. Sean Tepper Oh, that could be going live. Well, recording this video is, February 9th. That could go live on the 11th. Okay. So that’s a feature where you can, like, interact with where you’re going to be the first to hear about it here. So it’s it’s an AI tool where you can ask questions like how do I get started? Sean Tepper Or what should I do with my first thousand dollars? Or, what when is the best time to buy or best to sell? You can interact with AI and it’s actually connected with TYKRs, data set, but also the the globe and it’s put a lot of rigor, rigor into place to make sure it’s not giving you financial advice, but it’s really leaning into giving you the data and TYKR. Sean Tepper So it’s for example, if you were to ask it, hey, can you tell me how to value a stock? It’s going to first go to TYKRs data set. And with the education and give you that information. And then some general information. You know that makes it sound nicer. And then kind of spit it out. So yeah, eventually we’ll release in multiple phases. Sean Tepper So the first phase we call the helper, the second phase is the portfolio builder in a will build hypothetical like for example, build me a portfolio of ten strong tech stocks or buy food stocks or car stocks, something like that. Yeah. And of course it’ll say this is not financial advice. This is a hypothetical portfolio. But yes. And then the third phase will be an analyzer. Sean Tepper So analyze my current portfolio. Like what changes would you recommend. And that that’s going to be really, really cool. So with I will say this and then I’ll stop talking. It’s a powerful tool because it can analyze large data sets in a short amount of time. But as we say at TYKR. And this is why when I become self-aware like Skynet, I’m going to be the first one to be targeted. Sean Tepper Right? It’s, it’s smart, but it’s not that smart. So you have to put a lot of rigor in a place, a lot of guardrails, because it can, as you know, hallucinate. Yeah. So we are bouncing AI up against logic and mathematics to make sure it does not say something stupid to our customers. TFTC creating a trading bot program Andrew Mitchem That’s interesting. We’re in the middle of all we’re saying in the middle. We’ve been testing this live for over a year of getting AI to create trading bots for us, and what it’s doing is it’s spitting at a heap of bots and going through, sort of live trading on, on, you know, that are not real money. We’re trading on the money. Andrew Mitchem And then each week, we’re using the human aspect, the common sense and the knowledge that we look at as technical traders to pick which bots we’re going to be running live for subscribers for the upcoming week. And, and we’re finding that that combination of using the AI for that speed and, you know, doing the, the hard work. Andrew Mitchem Yeah. And giving us some information. But like you said, the guardrail becomes the human input in the common sense of what we’re seeing as technically on a chart. There’s no point in, let’s say, say Bitcoin over the last few weeks has been, you know, crashing. So nicely. There’s no point in us selecting bullish, crypto bots for the upcoming week when there’s technical traders. Andrew Mitchem We’re looking at it dropping. So I find that adding a bit of human common sense and knowledge, along with the AI at this stage is a really nice combination. Sean Tepper You got to do it right, and you probably seen the, the bad choices some people have made. If you let I make all the decisions, you can pull yourself into a, really bad situation. Especially. I like what you’re describing with your bots or those bots actually executing trades. Andrew Mitchem They they can, but we are more trying to set it up so the individual gets the alert and still needs to manually go yes or no as well. Good call. Because I don’t want to get into that situation where it’s completely, you know, automated, although a lot of people are want it all automated. My job as someone who teaches people is you still have to have that knowledge first to understand how to run the bots and to make a commonsense decision. Andrew Mitchem Is it making a good call or not? Sean Tepper Yeah, I’m good answer there, because the other hour I was talking to one company that was have was looking to have AI execute trades automatically. I’m like, whoa, what if they just run with the line and it’s like, go right? Like if rapid fire trades for an hour or two, it’s like, yeah, put some people in a bad situation. Sean Tepper So yeah. Andrew Mitchem Anyway, yeah, we’ll avoid that. We’re both avoid that. Yep. Yeah, exactly. I use it for the hard work and still use the brain. And that’s the thing, isn’t it? You know, what you created and what we’ve created. We’re about educating people, empowering people to use their common sense. Because I still think, after all, it comes down to it, there’s nothing better as a human, as an individual to have that, that how and that it’s almost like that feelgood factor that I know I can analyze these markets and make sound decisions and do well, you know, that’s you, you. Sean Tepper You, yeah. You just hit on the, the number one thing our customers care about like in and this will give you and your audience a little moment for me when I first created TYKR, especially the Excel sheet, I was all about getting better returns. I’m like, well, if Warren and Charlie can do it, I can do it. Sean Tepper Well, when I went live, that was my focus. But then after talking to a few customers, I’m like, they don’t agree with that. There’s actually something more important. And fast forward, I probably talked to a few thousand customers by this point over five years, and the number one thing they care about is confidence. Now, having confidence to literally do it on your own. Sean Tepper That is the home run. Feeling that supersedes, you know, getting good returns any day. Like people sleep better at night. Just knowing that, Shawn, I, I can do this on my own. That is what I’m looking for. I’m like home. So we even though the returns in tech are good, like, we actually lean into confidence. Like how do we give people more confidence is actually the bigger priority now. Andrew Mitchem Yeah, yeah, I, I fully get it. You know, we’ve been operating since 2009. Come on, Ryan, the Ryan run around the world in 111 countries and the same thing we we asked people, we, of course, you know, want to know why people join. And then we follow up after three months, six months, year, two years and keep asking people it’s the community and that knowledge of knowing what you’re doing for yourself, to have that control with low risk and, you know, really good outcomes. Andrew Mitchem But up here and then I say to people, trade any trading into, investments is emotion, isn’t it? Your head in your heart. You have to control those two. And what we’re doing is providing platforms or education platforms to allow people to fulfill that, that dream successfully and safely. Sean Tepper Yep, yep. Andrew Mitchem So it’s huge. Yeah. We can have all the AI and all the risks, all the all these flash gadgets, but ultimately it still comes back to that human wanting to have confidence in what they’re doing with their own money. Sean Tepper That’s it. Yeah. Andrew Mitchem And no. And also not just handing it over to someone as well. I think it’s important. Sean Tepper They add it and it’s actually you’re kind of alluding to this. It’s in people’s best interest to let’s say AI does 90% of the work. You want to be the person you want the human being finishing that process? Yeah. Because they, they ultimately it’s it’s better for them from an educational standpoint and from an, confidence standpoint, like they should know what was done. Sean Tepper But now, I control things. I get to execute the trade. Yes. You know, that’s right, that you want people to have that power at the end of the day. 60,000 stocks analyzed Andrew Mitchem Absolutely. And the, your software obviously does a lot of analysis just to give myself and viewers and listeners a ballpark figure. What kind of number of stocks is it kind of looking at and analyzing? Sean Tepper Sure. Okay. Yeah. So we’ve got about 60,000 stocks in TYKR around the world’s. We are up. Yeah. We’re upgrading. They’ll get this in the next month or two. We’re switching our data provider. So we’re going to have in the states real time pricing. You will have 15 minute delay. But then we’re going to have actually I can’t guarantee all stocks around the world, but most that’ll bring us closer to about 75,000 stocks around the world. Sean Tepper And then we’ll also have most ETFs around the world, which I think is closer to about 10,000. I could following in that Bow Wow. Yeah. No wonder. Andrew Mitchem They need analysis software that. Sean Tepper Yeah, right, right. It’s what we do. We run into circumstances when people, you know, they’ll join from a smaller country and they’ll be like, hey, you don’t have any stocks from our country. Winner may arriving. So it’s a lot of those requests and it’s like we knew we had to get to this point eventually. Yeah. But yeah. But then you just give transparency. Sean Tepper We’re looking at Finn Hub is, the data provider that will help us get, the more stocks and ETFs around the world. Andrew Mitchem Wow. So when you see your clients in 50 countries, if, for example, someone was here in New Zealand and they don’t want to be, and 2:00 in the morning to trade the US markets, they could be trading like the Australasian markets. Yeah. So your software. Sean Tepper Absolutely. Yep. Andrew Mitchem Oh, fantastic. That’s really good. Yeah. That, that’s blowing my way. That number. One thing as a currency trader, there’s like about eight main currencies. And so that makes, hence why there’s nothing like this for the forex market. I’m guessing because we can look at charts and read a bit of news and kind of make your analysis voice your, the information. Andrew Mitchem Someone out there with that. Your software is almost got an impossible task. Sean Tepper Yeah. We I was just checking here in tick or how many stocks from New Zealand. We’ve got a little over 187. So, do you know I like the I assume it’s the new New Zealand Stock Exchange. Andrew Mitchem Yes. In Wellington. Nice. Sean Tepper Got it. Do you know how many stocks they have? Andrew Mitchem No. I’m not, I’m purely forex. I honestly don’t know. Sean Tepper Okay. No no worries. But we’ll hopefully fin Hub will be able to get us most from from your exchange. Yeah. But that’s just a good example of like absolutely. You know we again we get a lot of people from random countries like, hey, can you add more stocks from our country? It’s like, yeah, absolutely. We’re we’re on it. Andrew Mitchem Yeah. Well, and also it’s purely that time of day thing, isn’t it. Because the you know, I suppose I get used to forex which is 24 hours a day. It doesn’t matter where you live in your world, you can trade it in cryptos obviously seven days a week now as well. But when you’re talking US stocks, they are, you know, for someone on my side of the world, some quite awkward trading hours. Andrew Mitchem So what you’re providing now would allow me to trade some of the the Japanese stocks, I’m guessing. Oh, and then the Australian ones using the ones now that you mentioned. So you really do open up your product to being truly a global, tool for people. Sean Tepper Exactly. Yeah. Yeah. Andrew Mitchem That’s awesome. Sean, anything else you want to add about what we’ve not covered, about what you can help people with? Sean Tepper Yeah. Knowing that you’re more in the trading world and we’re more investing, I have to say this one detail, which is we do have about 10% of our customers are traders, give or take, and they’ll use TYKR as their starting points. You’re like, hey, let’s see. You’ve got like 100 ideas out there. Well, they’ll use TYKR to narrow it down from 100 down to ten. Sean Tepper Yeah. So that’s one main use case. It’s kind of like the short AI, as it’s been described to me. Is the short list creator TYKRs, the short list for like for traders. So so yeah, I want to add that tidbit as some people are like, well I’m not really into best thing. It’s like, you don’t have to be. Sean Tepper You can just use the tool to, narrow down your search. So I’ve selected one use case. Andrew Mitchem Yeah, that makes a lot of sense. That’s kind of how I was thinking about potentially using it as well. It’s like, makes a lot of sense to do all that, that work and get it down to something more manageable. Right? Yeah. Contact Sean Andrew Mitchem And what’s the best way that someone can contact you to find out more, about what you offer? Andrew Mitchem Sure. Well, how would. Sean Tepper They add, two ways to get in touch with, TYKR or myself? You can just go to tykr.com. That’s TYKR, tykr.com. And then, I’m really active on LinkedIn. Sean Tepper, Sean is spelled the Sean Connery way. Andrew Mitchem Yes. This with the voice. Sean Tepper Yeah. I wish I had strong Scottish voice. Yes. Andrew Mitchem Awesome. Hey, Sean, we’ll put links, of course, up here as well. And we will be sharing this in around the website and social media as well, so people can contact you finding a link here as well. It’s been awesome talking to you. I’ve learned a lot about the market. I don’t know a huge amount, and it’s fascinating to hear what you do and how, you know, you going to make it from when you mentioned 60, it still blew me away. Andrew Mitchem That number, from a ridiculous number of, stocks to help to analyze something in a, in a more simplified way. So, awesome to speak to you. Thank you. Your product looks amazing. I will be trying it. And, Yeah, look forward to it as well. Sean Tepper Thanks, Andrew. This is great. Andrew Mitchem Awesome. Thanks, Sean. Bye for now. Episode Title: #624: The Smarter Way To Pick Winning Stocks Find out more about Blueberry Markets – Click Here Find out more about my Online Video Forex Course Book a Call with Andrew or one of his team now Click Here to Attend my Free Masterclass Checkout the Tykr Platform here.

In episode 281 of the Simple Flying podcast, your hosts Tom and Channing discuss,Delta increases Los Angeles-Melbourne frequenciesSpirit scrapping 3-year-old A320neosUnited backs GE for 787 powerLufthansa's 787 Allegris gets closerAmerican's Kentucky Derby flights

How should the US Air Force design itself to meet today's challenges – and tomorrow's? Tim Walton and Dan Patt of the Hudson Institute have a new report out with answers, and we'll take a good look at it. Plus the week's headlines in airpower. All powered by GE!

In this podcast, Greg Voisen sits down with serial entrepreneur and "Chief Connector" Larry Kesslin to explore his transformative new book, The Joy Molecule: How to Unlock the Power of Human Connection. Kesslin dismantles the traditional, box-checking definition of success that leaves so many high-achievers feeling hollow. If you've ever reached the summit of your career only to ask, "Is this all there is?", this conversation is your wake-up call. Larry shares the harrowing and humbling pivot points of his life—from a high-stakes engineering career at GE to a soul-stirring encounter with inner-city kids in Aspen—to reveal why happiness is fleeting, but joy is a biological and spiritual certainty you can unlock.

Dror Nir walks through pivotal S-curves of his career from Covid pivots to national leadership expansion. He explains how saying "yes" before you feel ready can unlock extraordinary progress. GE-8767015.1 ( 2/26)(Exp.2/30)

Instead of following trends, Satisfy chooses to build a brand that's different. Daniel said it best: “The easiest way to do something quite different is to not look at anything at all.”In a landscape where brands benchmark competitors and chase fleeting trends, Satisfy focuses on culture. They hire for it before skill, treat customers as guests, and think in decades rather than moments.This philosophy shines through in the Satisfy Pro Team. It's not just a sponsorship roster, but a reflection of the brand's commitment to process and discipline. The key takeaway: Most brands chase relevance, but Satisfy builds consistency. They react to culture, while Satisfy hires for it. They aim for long-term impact, not short-term hype.This conversation is a masterclass in long-term brand strategy and the discipline of saying no.Watch the video version of this podcast on Youtube ▶️: https://youtu.be/CRUMwdDoj5o

What if the climate crisis didn't have to be framed as a doomsday story but instead as a catalyst for innovation, collaboration, and global renewal?In this powerful episode of A Voice and Beyond, host Dr Marisa Lee Naismith sits down with Russ Walsh, cybersecurity executive, systems thinker, and founder of The SeaNet, a bold initiative designed to address one of the greatest challenges facing humanity: rising sea levels.After decades working with global technology leaders including IBM, Google, Apple, GE, and Facebook, Russ began asking a deeper question — what if we could apply systems-level thinking to climate change the same way we do to cybersecurity and infrastructure?In this conversation, Russ unpacks the science behind sea-level rise, why fear-based climate narratives leave people frozen, and how vision, leadership, and collective action can turn crisis into opportunity. This episode invites listeners to move beyond overwhelm and into empowered participation in shaping the future of our planet.If you've ever felt anxious, helpless, or disconnected when it comes to climate change, this episode offers clarity, hope, and a radically new way forward.Find Russ Here:Website: https://russwalsh.com/LinkedIn: https://www.linkedin.com/in/russwalsh/Books:The SeaNet Vision: Stop Rising Seas & Turn Melting Ice into Blue Gold https://russwalsh.com/the-book/Eternity: Where will you spend it? - https://a.co/d/4BvyB8mFind Marisa online: Website: https://drmarisaleenaismith.com/ LinkedIn: https://www.linkedin.com/in/drmarisaleenaismith/ Instagram: https://www.instagram.com/drmarisaleenaismith/ Facebook: https://www.facebook.com/marisa.lee.12 YouTube: https://www.youtube.com/@avoiceandbeyond3519/videos Resources: MLN Coaching Program: https://drmarisaleenaismith.com/mentoring/ Schedule a Free Clarity Call: https://calendly.com/info-56015/discovery Gratitude Journal: https://drmarisaleenaismith.com/product/in-gratitude-my-daily-self-journal/ Download your eBook: Thriving in a Creative Industry: https://drmarisaleenaismith.com/product/ebook-thriving-in-a-creative-industry-dr-marisa-lee-naismith/ Like this episode? Please leave a review here - even ...

Adam Coffey is a visionary leader who drives growth and builds great cultures. Adam is an Army veteran, a former GE executive, and served as CEO of three service companies for over 20 years. He is the bestselling author of four books, including Empire Builder and The Private Equity Playbook. Adam is currently Chairman of The Chairman Group, a world class consulting business. Adam joined host Robert Glazer on the Elevate Podcast to talk about leadership lessons from two decades as a CEO, GE's approach to leadership training, and much more. Thank you to the sponsors of The Elevate Podcast Shopify: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠shopify.com/elevate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Masterclass: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠masterclass.com/elevate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Framer: ⁠⁠⁠framer.com/elevate⁠⁠⁠ Northwest Registered Agent: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠northwestregisteredagent.com/elevatefree⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Homeserve: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠homeserve.com⁠⁠⁠⁠⁠ Indeed: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠indeed.com/elevate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Vanguard: ⁠vanguard.com/audio Learn more about your ad choices. Visit megaphone.fm/adchoices